{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 16,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 5
      },
      "2": {
        "core": 1,
        "branch": 4
      },
      "3": {
        "core": 1,
        "branch": 4
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 ∨ G)",
        "prover9_expression": "(approves(person, drug) | generic_drug(drug))",
        "natural": "Either a person approves a drug or the drug is a generic drug."
      },
      {
        "id": "Rule2",
        "formal": "(A10 → (A8 → ¬A9))",
        "prover9_expression": "(monitors(agency, financial_firm) -> (violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product)))",
        "natural": "If an agency monitors a financial firm, then whenever that firm violates a regulation with a financial product, it does not face a fine for that product."
      },
      {
        "id": "Rule3",
        "formal": "(A12 → A11)",
        "prover9_expression": "(investigates(agency, financial_firm) -> audits(agency, financial_firm))",
        "natural": "Provided that an agency investigates a financial firm, it also audits that firm."
      },
      {
        "id": "Rule4",
        "formal": "(A15 → A18)",
        "prover9_expression": "(high_risk_product(financial_product) -> requires_licensing(financial_product))",
        "natural": "Should a financial product be high risk, it requires licensing."
      },
      {
        "id": "Rule5",
        "formal": "(A15 → A67)",
        "prover9_expression": "(high_risk_product(financial_product) -> leverage_limits(financial_product))",
        "natural": "Given that a financial product is high risk, it has leverage limits."
      },
      {
        "id": "Rule6",
        "formal": "(A15 ∨ A16)",
        "prover9_expression": "(high_risk_product(financial_product) | medium_risk_product(financial_product))",
        "natural": "A financial product is either high risk or medium risk."
      },
      {
        "id": "Rule7",
        "formal": "(A16 → (¬(A13 ∨ G) → A14))",
        "prover9_expression": "(medium_risk_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "Assuming a financial product is medium risk, then provided that the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      {
        "id": "Rule8",
        "formal": "(A17 → (¬(A13 ∨ G) → A14))",
        "prover9_expression": "(requires_disclosure(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "If a financial product requires disclosure, then in the event that the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      {
        "id": "Rule9",
        "formal": "(A18 → A17)",
        "prover9_expression": "(requires_licensing(financial_product) -> requires_disclosure(financial_product))",
        "natural": "Provided that a financial product requires licensing, it also requires disclosure."
      },
      {
        "id": "Rule10",
        "formal": "(A19 → A20)",
        "prover9_expression": "(conflicting_policy(agency) -> supports_industry(agency))",
        "natural": "Whenever an agency has conflicting policy, it supports the industry."
      },
      {
        "id": "Rule11",
        "formal": "(A19 → ¬A20)",
        "prover9_expression": "(conflicting_policy(agency) -> -supports_industry(agency))",
        "natural": "In case an agency has conflicting policy, it does not support the industry."
      },
      {
        "id": "Rule12",
        "formal": "(A19 ∨ (A6 → (¬(A2 → A4) → A5)))",
        "prover9_expression": "(conflicting_policy(agency) | (proposes_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product))))",
        "natural": "Either an agency has conflicting policy, or if a legislator proposes legislation for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      {
        "id": "Rule13",
        "formal": "(A2 ∨ A3)",
        "prover9_expression": "(investigates(agency, financial_product) | bans(agency, financial_product))",
        "natural": "An agency either investigates a financial product or bans that product."
      },
      {
        "id": "Rule14",
        "formal": "(A21 → A22)",
        "prover9_expression": "(drafts_bill(legislator, financial_product) -> sponsors_bill(legislator, financial_product))",
        "natural": "If a legislator drafts a bill for a financial product, then that legislator sponsors the bill for the product."
      },
      {
        "id": "Rule15",
        "formal": "(A22 → (¬(A2 → A4) → A5))",
        "prover9_expression": "(sponsors_bill(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
        "natural": "Provided that a legislator sponsors a bill for a financial product, then in case the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      {
        "id": "Rule16",
        "formal": "(A23 ∨ ¬A1)",
        "prover9_expression": "(safe_investment(financial_product) | -approves(person, drug))",
        "natural": "Either a financial product is a safe investment or a person does not approve a drug."
      },
      {
        "id": "Rule17",
        "formal": "(A25 → A24)",
        "prover9_expression": "(approved_fund(financial_product) -> regulated_investment(financial_product))",
        "natural": "If a financial product is an approved fund, then it is a regulated investment."
      },
      {
        "id": "Rule18",
        "formal": "(A26 → ¬A23)",
        "prover9_expression": "(restricted_fund(financial_product) -> -safe_investment(financial_product))",
        "natural": "Provided that a financial product is a restricted fund, it is not a safe investment."
      },
      {
        "id": "Rule19",
        "formal": "(A27 → A25)",
        "prover9_expression": "(established_fund(financial_product) -> approved_fund(financial_product))",
        "natural": "In case a financial product is an established fund, it is an approved fund."
      },
      {
        "id": "Rule20",
        "formal": "(A28 → A26)",
        "prover9_expression": "(new_fund(financial_product) -> restricted_fund(financial_product))",
        "natural": "Should a financial product be a new fund, then it is a restricted fund."
      },
      {
        "id": "Rule21",
        "formal": "(A29 → A27)",
        "prover9_expression": "(domestic_fund(financial_product) -> established_fund(financial_product))",
        "natural": "If a financial product is a domestic fund, then it is an established fund."
      },
      {
        "id": "Rule22",
        "formal": "(A3 → ¬A1)",
        "prover9_expression": "(bans(agency, financial_product) -> -approves(person, drug))",
        "natural": "Provided that an agency bans a financial product, a person does not approve a drug."
      },
      {
        "id": "Rule23",
        "formal": "(A30 → A28)",
        "prover9_expression": "(foreign_fund(financial_product) -> new_fund(financial_product))",
        "natural": "In case a financial product is a foreign fund, then it is a new fund."
      },
      {
        "id": "Rule24",
        "formal": "(A32 → (A31 ∨ (A29 ∨ A30)))",
        "prover9_expression": "(investment_product(financial_product) -> (hybrid_fund(financial_product) | (domestic_fund(financial_product) | foreign_fund(financial_product))))",
        "natural": "If a financial product is an investment product, then it is either a hybrid fund, or a domestic fund, or a foreign fund."
      },
      {
        "id": "Rule25",
        "formal": "(A35 → ¬A34)",
        "prover9_expression": "(normal_market_conditions(financial_product) -> -emergency_action(agency, financial_product))",
        "natural": "Provided that a financial product is under normal market conditions, the agency does not take emergency action on that product."
      },
      {
        "id": "Rule26",
        "formal": "(A38 → ¬A37)",
        "prover9_expression": "(economic_stability(financial_product) -> -market_crash(financial_product))",
        "natural": "In case a financial product contributes to economic stability, it does not experience a market crash."
      },
      {
        "id": "Rule27",
        "formal": "(A4 → ¬A1)",
        "prover9_expression": "(finds_risky(agency, financial_product) -> -approves(person, drug))",
        "natural": "Should an agency find a financial product risky, then a person does not approve a drug."
      },
      {
        "id": "Rule28",
        "formal": "(A40 → A39)",
        "prover9_expression": "(boom_period(financial_product) -> growth_period(financial_product))",
        "natural": "If a financial product is in a boom period, then it is in a growth period."
      },
      {
        "id": "Rule29",
        "formal": "(A41 → (A2 → ¬A1))",
        "prover9_expression": "(initial_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug)))",
        "natural": "Whenever an agency conducts an initial review of a financial product, then if it investigates that product, a person does not approve a drug."
      },
      {
        "id": "Rule30",
        "formal": "(A41 ∨ A42)",
        "prover9_expression": "(initial_review(agency, financial_product) | followup_review(agency, financial_product))",
        "natural": "An agency either conducts an initial review of a financial product or a followup review of that product."
      },
      {
        "id": "Rule31",
        "formal": "(A43 ∨ (A42 → (A2 → ¬A1)))",
        "prover9_expression": "(compliant_product(financial_product) | (followup_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug))))",
        "natural": "Either a financial product is compliant, or if the agency conducts a followup review of the product, then whenever it investigates the product, a person does not approve a drug."
      },
      {
        "id": "Rule32",
        "formal": "(A46 → A45)",
        "prover9_expression": "(major_violation(financial_product) -> minor_violation(financial_product))",
        "natural": "In case a financial product has a major violation, then it has a minor violation."
      },
      {
        "id": "Rule33",
        "formal": "(A47 ∨ (¬(A44 ∨ ¬A43) → A46))",
        "prover9_expression": "(pending_investigation(financial_product) | (-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> major_violation(financial_product)))",
        "natural": "A financial product is under pending investigation, or if the product is not noncompliant and not compliant, then it has a major violation."
      },
      {
        "id": "Rule34",
        "formal": "(A49 → ¬A48)",
        "prover9_expression": "(standard_compliance(financial_firm, financial_product) -> -regulatory_exception(financial_firm, financial_product))",
        "natural": "Should a financial firm follow standard compliance for a financial product, then it does not have a regulatory exception for that product."
      },
      {
        "id": "Rule35",
        "formal": "(A49 ∨ A50)",
        "prover9_expression": "(standard_compliance(financial_firm, financial_product) | enhanced_compliance(financial_firm, financial_product))",
        "natural": "A financial firm either follows standard compliance for a financial product or enhanced compliance for that product."
      },
      {
        "id": "Rule36",
        "formal": "(A50 → ¬A48)",
        "prover9_expression": "(enhanced_compliance(financial_firm, financial_product) -> -regulatory_exception(financial_firm, financial_product))",
        "natural": "Provided that a financial firm follows enhanced compliance for a financial product, it does not have a regulatory exception for that product."
      },
      {
        "id": "Rule37",
        "formal": "(A52 ∨ (A51 → ¬A8))",
        "prover9_expression": "(internal_audit(financial_firm) | (whistleblower_report(person, financial_firm) -> -violates_regulation(financial_firm, financial_product)))",
        "natural": "Either a financial firm conducts an internal audit, or if a person submits a whistleblower report about the firm, then the firm does not violate a regulation with a financial product."
      },
      {
        "id": "Rule38",
        "formal": "(A55 → (A54 → (A8 → A53)))",
        "prover9_expression": "(senior_approval(financial_firm, financial_product) -> (compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))))",
        "natural": "Provided that a financial firm obtains senior approval for a financial product, then if it undergoes a compliance officer review for the product, and the firm violates a regulation with the product, it takes corrective action for the product."
      },
      {
        "id": "Rule39",
        "formal": "(A55 ∨ A56)",
        "prover9_expression": "(senior_approval(financial_firm, financial_product) | committee_approval(financial_firm, financial_product))",
        "natural": "A financial firm either obtains senior approval for a financial product or committee approval for that product."
      },
      {
        "id": "Rule40",
        "formal": "(A56 → (A54 → (A8 → A53)))",
        "prover9_expression": "(committee_approval(financial_firm, financial_product) -> (compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))))",
        "natural": "In case a financial firm obtains committee approval for a financial product, then if it undergoes a compliance officer review for the product, and the firm violates a regulation with the product, it takes corrective action for the product."
      },
      {
        "id": "Rule41",
        "formal": "(A57 → ¬A9)",
        "prover9_expression": "(self_reporting(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product))",
        "natural": "Should a financial firm self-report for a financial product, then it does not face a fine for that product."
      },
      {
        "id": "Rule42",
        "formal": "(A59 → A57)",
        "prover9_expression": "(mandatory_disclosure(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
        "natural": "In case a financial firm makes a mandatory disclosure for a financial product, then it self-reports for that product."
      },
      {
        "id": "Rule43",
        "formal": "(A6 → A21)",
        "prover9_expression": "(proposes_legislation(legislator, financial_product) -> drafts_bill(legislator, financial_product))",
        "natural": "If a legislator proposes legislation for a financial product, then that legislator drafts a bill for the product."
      },
      {
        "id": "Rule44",
        "formal": "(A6 → A7)",
        "prover9_expression": "(proposes_legislation(legislator, financial_product) -> amends_legislation(legislator, financial_product))",
        "natural": "Provided that a legislator proposes legislation for a financial product, then that legislator amends legislation for the product."
      },
      {
        "id": "Rule45",
        "formal": "(A63 → A65)",
        "prover9_expression": "(complex_product(financial_product) -> structured_product(financial_product))",
        "natural": "If a financial product is complex, then it is structured."
      },
      {
        "id": "Rule46",
        "formal": "(A63 ∨ A64)",
        "prover9_expression": "(complex_product(financial_product) | simple_product(financial_product))",
        "natural": "A financial product is either complex or simple."
      },
      {
        "id": "Rule47",
        "formal": "(A64 → (¬(A13 ∨ G) → A14))",
        "prover9_expression": "(simple_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "Provided that a financial product is simple, then whenever the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      {
        "id": "Rule48",
        "formal": "(A65 → (¬(A13 ∨ G) → A14))",
        "prover9_expression": "(structured_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "Should a financial product be structured, then in the event that the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      {
        "id": "Rule49",
        "formal": "(A66 → A17)",
        "prover9_expression": "(capital_requirements(financial_product) -> requires_disclosure(financial_product))",
        "natural": "If a financial product has capital requirements, then it requires disclosure."
      },
      {
        "id": "Rule50",
        "formal": "(A68 → (A67 → A66))",
        "prover9_expression": "(risk_assessment(financial_product) -> (leverage_limits(financial_product) -> capital_requirements(financial_product)))",
        "natural": "Whenever a financial product undergoes risk assessment, then if it has leverage limits, it has capital requirements."
      },
      {
        "id": "Rule51",
        "formal": "(A69 → (A67 → A66))",
        "prover9_expression": "(stress_testing(financial_product) -> (leverage_limits(financial_product) -> capital_requirements(financial_product)))",
        "natural": "In case a financial product undergoes stress testing, then provided that it has leverage limits, it has capital requirements."
      },
      {
        "id": "Rule52",
        "formal": "(A7 → (¬(A2 → A4) → A5))",
        "prover9_expression": "(amends_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
        "natural": "Should a legislator amend legislation for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      {
        "id": "Rule53",
        "formal": "(A70 → (A68 ∨ A69))",
        "prover9_expression": "(quarterly_review(financial_product) -> (risk_assessment(financial_product) | stress_testing(financial_product)))",
        "natural": "If a financial product has a quarterly review, then it either undergoes risk assessment or stress testing."
      },
      {
        "id": "Rule54",
        "formal": "(A70 ∨ A71)",
        "prover9_expression": "(quarterly_review(financial_product) | annual_review(financial_product))",
        "natural": "A financial product either has a quarterly review or an annual review."
      },
      {
        "id": "Rule55",
        "formal": "(A71 → (A68 ∨ A69))",
        "prover9_expression": "(annual_review(financial_product) -> (risk_assessment(financial_product) | stress_testing(financial_product)))",
        "natural": "Provided that a financial product has an annual review, then it either undergoes risk assessment or stress testing."
      },
      {
        "id": "Rule56",
        "formal": "(A73 → A72)",
        "prover9_expression": "(conditional_approval(drug) -> full_approval(drug))",
        "natural": "In case a drug receives conditional approval, then it receives full approval."
      },
      {
        "id": "Rule57",
        "formal": "(A75 → (A13 ∨ G))",
        "prover9_expression": "(phase1_trial(drug) -> (approved_for_sale(drug) | generic_drug(drug)))",
        "natural": "If a drug is in phase 1 trial, then it is either approved for sale or a generic drug."
      },
      {
        "id": "Rule58",
        "formal": "(A76 → (A13 ∨ G))",
        "prover9_expression": "(phase2_trial(drug) -> (approved_for_sale(drug) | generic_drug(drug)))",
        "natural": "Provided that a drug is in phase 2 trial, then it is either approved for sale or a generic drug."
      },
      {
        "id": "Rule59",
        "formal": "(A78 → (A77 → (A75 ∨ A76)))",
        "prover9_expression": "(research_funding(drug) -> (clinical_research(drug) -> (phase1_trial(drug) | phase2_trial(drug))))",
        "natural": "If a drug receives research funding, then whenever it is in clinical research, it is either in phase 1 trial or phase 2 trial."
      },
      {
        "id": "Rule60",
        "formal": "(A8 → A58)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> voluntary_disclosure(financial_firm, financial_product))",
        "natural": "Should a financial firm violate a regulation with a financial product, it makes a voluntary disclosure for that product."
      },
      {
        "id": "Rule61",
        "formal": "(A8 → A9)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> faces_fine(financial_firm, financial_product))",
        "natural": "If a financial firm violates a regulation with a financial product, then it faces a fine for that product."
      },
      {
        "id": "Rule62",
        "formal": "(A8 ∨ G)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) | generic_drug(drug))",
        "natural": "Either a financial firm violates a regulation with a financial product or a drug is a generic drug."
      },
      {
        "id": "Rule63",
        "formal": "(¬(A13 ∨ G) → ¬A14)",
        "prover9_expression": "(-(approved_for_sale(drug) | generic_drug(drug)) -> -restricted_use(drug))",
        "natural": "Should the drug not be approved for sale and not be a generic drug, then it is not for restricted use."
      },
      {
        "id": "Rule64",
        "formal": "(¬(A33 → (A2 → A4)) → A34)",
        "prover9_expression": "(-(routine_inspection(agency, financial_product) -> (investigates(agency, financial_product) -> finds_risky(agency, financial_product))) -> emergency_action(agency, financial_product))",
        "natural": "Provided that it is not the case that if the agency performs a routine inspection on a financial product, then if it investigates that product, it finds the product risky, the agency takes emergency action on that product."
      },
      {
        "id": "Rule65",
        "formal": "(¬(A44 ∨ ¬A43) → ¬A45)",
        "prover9_expression": "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> -minor_violation(financial_product))",
        "natural": "Provided that the financial product is not noncompliant and not compliant, it does not have a minor violation."
      },
      {
        "id": "Rule66",
        "formal": "(¬(A58 → A59) → A60)",
        "prover9_expression": "(-(voluntary_disclosure(financial_firm, financial_product) -> mandatory_disclosure(financial_firm, financial_product)) -> extended_deadline(financial_firm, financial_product))",
        "natural": "Whenever it is not the case that if a financial firm makes a voluntary disclosure for a financial product, then it makes a mandatory disclosure for that product, the firm has an extended deadline for the product."
      },
      {
        "id": "Rule67",
        "formal": "(¬(A60 → A61) → A62)",
        "prover9_expression": "(-(extended_deadline(financial_firm, financial_product) -> granted_extension(financial_firm, financial_product)) -> denied_extension(financial_firm, financial_product))",
        "natural": "In case it is not the case that if a financial firm has an extended deadline for a financial product, then it is granted an extension for that product, the firm is denied an extension for the product."
      },
      {
        "id": "Rule68",
        "formal": "(¬(A8 → ¬A9) → A48)",
        "prover9_expression": "(-(violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product)) -> regulatory_exception(financial_firm, financial_product))",
        "natural": "Should it not be the case that if a financial firm violates a regulation with a financial product, then it does not face a fine for that product, the firm has a regulatory exception for the product."
      },
      {
        "id": "Rule69",
        "formal": "(¬(¬(¬(A13 ∨ G) → A14) → A73) → A74)",
        "prover9_expression": "(-(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug)) -> fast_track_approval(drug))",
        "natural": "Should it not be the case that if it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, then the drug receives conditional approval, the drug receives fast-track approval."
      },
      {
        "id": "Rule70",
        "formal": "(¬(¬(¬(A13 ∨ G) → A14) → A73) → ¬A74)",
        "prover9_expression": "(-(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug)) -> -fast_track_approval(drug))",
        "natural": "Provided that it is not the case that if it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, then the drug receives conditional approval, the drug does not receive fast-track approval."
      },
      {
        "id": "Rule71",
        "formal": "(¬(¬A35 → A36) → A37)",
        "prover9_expression": "(-(-normal_market_conditions(financial_product) -> volatile_market(financial_product)) -> market_crash(financial_product))",
        "natural": "In case it is not the case that if the financial product is not under normal market conditions, then it is in a volatile market, the product experiences a market crash."
      },
      {
        "id": "Rule72",
        "formal": "(¬A10 → A12)",
        "prover9_expression": "(-monitors(agency, financial_firm) -> investigates(agency, financial_firm))",
        "natural": "Provided that an agency does not monitor a financial firm, it investigates that firm."
      },
      {
        "id": "Rule73",
        "formal": "(¬A38 → A40)",
        "prover9_expression": "(-economic_stability(financial_product) -> boom_period(financial_product))",
        "natural": "Provided that a financial product does not contribute to economic stability, it is in a boom period."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A32",
        "prover9_expression": "investment_product(financial_product)",
        "natural": "A financial product is an investment product."
      },
      {
        "id": "Fact2",
        "formal": "A33",
        "prover9_expression": "routine_inspection(agency, financial_product)",
        "natural": "An agency performs a routine inspection on a financial product."
      },
      {
        "id": "Fact3",
        "formal": "A51",
        "prover9_expression": "whistleblower_report(person, financial_firm)",
        "natural": "A person submits a whistleblower report about a financial firm."
      },
      {
        "id": "Fact4",
        "formal": "A54",
        "prover9_expression": "compliance_officer_review(financial_firm, financial_product)",
        "natural": "A financial firm undergoes a compliance officer review for a financial product."
      },
      {
        "id": "Fact5",
        "formal": "A6",
        "prover9_expression": "proposes_legislation(legislator, financial_product)",
        "natural": "A legislator proposes legislation for a financial product."
      },
      {
        "id": "Fact6",
        "formal": "A77",
        "prover9_expression": "clinical_research(drug)",
        "natural": "A drug is in clinical research."
      },
      {
        "id": "Fact7",
        "formal": "A78",
        "prover9_expression": "research_funding(drug)",
        "natural": "A drug receives research funding."
      },
      {
        "id": "Fact8",
        "formal": "¬A11",
        "prover9_expression": "-audits(agency, financial_firm)",
        "natural": "It is not the case that an agency audits a financial firm."
      },
      {
        "id": "Fact9",
        "formal": "¬A13",
        "prover9_expression": "-approved_for_sale(drug)",
        "natural": "It is not the case that a drug is approved for sale."
      },
      {
        "id": "Fact10",
        "formal": "¬A24",
        "prover9_expression": "-regulated_investment(financial_product)",
        "natural": "It is not the case that a financial product is a regulated investment."
      },
      {
        "id": "Fact11",
        "formal": "¬A31",
        "prover9_expression": "-hybrid_fund(financial_product)",
        "natural": "It is not the case that a financial product is a hybrid fund."
      },
      {
        "id": "Fact12",
        "formal": "¬A36",
        "prover9_expression": "-volatile_market(financial_product)",
        "natural": "It is not the case that a financial product is in a volatile market."
      },
      {
        "id": "Fact13",
        "formal": "¬A39",
        "prover9_expression": "-growth_period(financial_product)",
        "natural": "It is not the case that a financial product is in a growth period."
      },
      {
        "id": "Fact14",
        "formal": "¬A44",
        "prover9_expression": "-noncompliant_product(financial_product)",
        "natural": "It is not the case that a financial product is noncompliant."
      },
      {
        "id": "Fact15",
        "formal": "¬A47",
        "prover9_expression": "-pending_investigation(financial_product)",
        "natural": "It is not the case that a financial product is under pending investigation."
      },
      {
        "id": "Fact16",
        "formal": "¬A5",
        "prover9_expression": "-issues_warning(agency, financial_product)",
        "natural": "It is not the case that an agency issues a warning for a financial product."
      },
      {
        "id": "Fact17",
        "formal": "¬A52",
        "prover9_expression": "-internal_audit(financial_firm)",
        "natural": "It is not the case that a financial firm conducts an internal audit."
      },
      {
        "id": "Fact18",
        "formal": "¬A53",
        "prover9_expression": "-corrective_action(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm takes corrective action for a financial product."
      },
      {
        "id": "Fact19",
        "formal": "¬A61",
        "prover9_expression": "-granted_extension(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm is granted an extension for a financial product."
      },
      {
        "id": "Fact20",
        "formal": "¬A62",
        "prover9_expression": "-denied_extension(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm is denied an extension for a financial product."
      },
      {
        "id": "Fact21",
        "formal": "¬A72",
        "prover9_expression": "-full_approval(drug)",
        "natural": "It is not the case that a drug receives full approval."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "generic_drug(drug)",
    "natural": "A drug is a generic drug."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A6 -> A7)",
            "(A7 -> (-(A2 -> A4) -> A5))"
          ],
          "conclusion": "(A6 -> (-(A2 -> A4) -> A5))",
          "natural": "Whenever a legislator proposes legislation for a financial product, then if the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A6 -> (-(A2 -> A4) -> A5))",
            "A6"
          ],
          "conclusion": "(-(A2 -> A4) -> A5)",
          "natural": "Whenever the agency does not investigate a financial product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A2 -> A4) -> A5)",
            "-A5"
          ],
          "conclusion": "(A2 -> A4)",
          "natural": "If an agency investigates a financial product, then it finds that product risky."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A2 -> A4)",
            "(A4 -> -A1)"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "Provided that an agency investigates a financial product, a person does not approve a drug."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that a person approves a drug."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-A10 -> A12)",
            "(A12 -> A11)"
          ],
          "conclusion": "(-A10 -> A11)",
          "natural": "Should an agency not monitor a financial firm, then it audits that firm."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-A10 -> A11)",
            "-A11"
          ],
          "conclusion": "A10",
          "natural": "An agency monitors a financial firm."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A10 -> (A8 -> -A9))",
            "A10"
          ],
          "conclusion": "(A8 -> -A9)",
          "natural": "Provided that a financial firm violates a regulation with a financial product, it does not face a fine for that product."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A8 -> A9)",
            "(A8 -> -A9)"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that a financial firm violates a regulation with a financial product."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | G)",
            "-A8"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A18)",
            "(A18 -> A17)"
          ],
          "conclusion": "(A15 -> A17)",
          "natural": "Whenever a financial product is high risk, it requires disclosure."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A17)",
            "(A17 -> (-(A13 | G) -> A14))"
          ],
          "conclusion": "(A15 -> (-(A13 | G) -> A14))",
          "natural": "In case a financial product is high risk, then if the drug is neither approved for sale nor a generic drug, the drug is for restricted use."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A15 | A16)",
            "(A15 -> (-(A13 | G) -> A14))",
            "(A16 -> (-(A13 | G) -> A14))"
          ],
          "conclusion": "(-(A13 | G) -> A14)",
          "natural": "In case the drug is not approved for sale and not a generic drug, then the drug is for restricted use."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A13 | G) -> A14)",
            "(-(A13 | G) -> -A14)"
          ],
          "conclusion": "(A13 | G)",
          "natural": "Either a drug is approved for sale or it is a generic drug."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A13 | G)",
            "-A13"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(A19 -> A20)",
            "(A19 -> -A20)"
          ],
          "conclusion": "-A19",
          "natural": "It is not the case that an agency has conflicting policy."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A6 -> (-(A2 -> A4) -> A5)))",
            "-A19"
          ],
          "conclusion": "(A6 -> (-(A2 -> A4) -> A5))",
          "natural": "Whenever a legislator proposes legislation for a financial product, then if the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A6 -> (-(A2 -> A4) -> A5))",
            "A6"
          ],
          "conclusion": "(-(A2 -> A4) -> A5)",
          "natural": "Whenever the agency does not investigate a financial product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A2 -> A4) -> A5)",
            "-A5"
          ],
          "conclusion": "(A2 -> A4)",
          "natural": "If an agency investigates a financial product, then it finds that product risky."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A2 -> A4)",
            "(A4 -> -A1)"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "Provided that an agency investigates a financial product, a person does not approve a drug."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that a person approves a drug."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A21 -> A22)",
            "(A22 -> (-(A2 -> A4) -> A5))"
          ],
          "conclusion": "(A21 -> (-(A2 -> A4) -> A5))",
          "natural": "Should a legislator draft a bill for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A6 -> A21)",
            "(A21 -> (-(A2 -> A4) -> A5))"
          ],
          "conclusion": "(A6 -> (-(A2 -> A4) -> A5))",
          "natural": "Whenever a legislator proposes legislation for a financial product, then if the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A6 -> (-(A2 -> A4) -> A5))",
            "A6"
          ],
          "conclusion": "(-(A2 -> A4) -> A5)",
          "natural": "Whenever the agency does not investigate a financial product, and it finds the product risky, the agency issues a warning for the product."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A2 -> A4) -> A5)",
            "-A5"
          ],
          "conclusion": "(A2 -> A4)",
          "natural": "If an agency investigates a financial product, then it finds that product risky."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A2 -> A4)",
            "(A4 -> -A1)"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "Provided that an agency investigates a financial product, a person does not approve a drug."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that a person approves a drug."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 4,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A32 -> (A31 | (A29 | A30)))",
            "A32"
          ],
          "conclusion": "(A31 | (A29 | A30))",
          "natural": "A financial product is a hybrid fund, or it is either a domestic fund or a foreign fund."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A31 | (A29 | A30))",
            "-A31"
          ],
          "conclusion": "(A29 | A30)",
          "natural": "A financial product is either a domestic fund or a foreign fund."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A29 -> A27)",
            "(A30 -> A28)",
            "(A29 | A30)"
          ],
          "conclusion": "(A27 | A28)",
          "natural": "A financial product is either an established fund or a new fund."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A27 -> A25)",
            "(A28 -> A26)",
            "(A27 | A28)"
          ],
          "conclusion": "(A25 | A26)",
          "natural": "A financial product is either an approved fund or a restricted fund."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A25 -> A24)",
            "(A26 -> -A23)",
            "(A25 | A26)"
          ],
          "conclusion": "(A24 | -A23)",
          "natural": "A financial product is a regulated investment or it is not a safe investment."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A24 | -A23)",
            "-A24"
          ],
          "conclusion": "-A23",
          "natural": "It is not the case that a financial product is a safe investment."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A23 | -A1)",
            "-A23"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that a person approves a drug."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-A38 -> A40)",
            "(A40 -> A39)"
          ],
          "conclusion": "(-A38 -> A39)",
          "natural": "In case a financial product does not contribute to economic stability, then it is in a growth period."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-A38 -> A39)",
            "-A39"
          ],
          "conclusion": "A38",
          "natural": "A financial product contributes to economic stability."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A38 -> -A37)",
            "A38"
          ],
          "conclusion": "-A37",
          "natural": "It is not the case that a financial product experiences a market crash."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-A35 -> A36) -> A37)",
            "-A37"
          ],
          "conclusion": "(-A35 -> A36)",
          "natural": "If a financial product is not under normal market conditions, then it is in a volatile market."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-A35 -> A36)",
            "-A36"
          ],
          "conclusion": "A35",
          "natural": "A financial product is under normal market conditions."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A35 -> -A34)",
            "A35"
          ],
          "conclusion": "-A34",
          "natural": "It is not the case that an agency takes emergency action on a financial product."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A33 -> (A2 -> A4)) -> A34)",
            "-A34"
          ],
          "conclusion": "(A33 -> (A2 -> A4))",
          "natural": "Whenever an agency performs a routine inspection on a financial product, then if it investigates that product, it finds the product risky."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A33 -> (A2 -> A4))",
            "A33"
          ],
          "conclusion": "(A2 -> A4)",
          "natural": "If an agency investigates a financial product, then it finds that product risky."
        },
        {
          "step_number": 9,
          "rule_applied": "HS",
          "premises_used": [
            "(A2 -> A4)",
            "(A4 -> -A1)"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "Provided that an agency investigates a financial product, a person does not approve a drug."
        },
        {
          "step_number": 10,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that a person approves a drug."
        },
        {
          "step_number": 11,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A47 | (-(A44 | -A43) -> A46))",
            "-A47"
          ],
          "conclusion": "(-(A44 | -A43) -> A46)",
          "natural": "Should the financial product not be noncompliant and not be compliant, then it has a major violation."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A44 | -A43) -> A46)",
            "(A46 -> A45)"
          ],
          "conclusion": "(-(A44 | -A43) -> A45)",
          "natural": "In case the financial product is not noncompliant and not compliant, then it has a minor violation."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A44 | -A43) -> A45)",
            "(-(A44 | -A43) -> -A45)"
          ],
          "conclusion": "(A44 | -A43)",
          "natural": "A financial product is noncompliant or it is not compliant."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A44 | -A43)",
            "-A44"
          ],
          "conclusion": "-A43",
          "natural": "It is not the case that a financial product is compliant."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A43 | (A42 -> (A2 -> -A1)))",
            "-A43"
          ],
          "conclusion": "(A42 -> (A2 -> -A1))",
          "natural": "Provided that an agency conducts a followup review of a financial product, then if it investigates that product, a person does not approve a drug."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A41 | A42)",
            "(A41 -> (A2 -> -A1))",
            "(A42 -> (A2 -> -A1))"
          ],
          "conclusion": "(A2 -> -A1)",
          "natural": "Provided that an agency investigates a financial product, a person does not approve a drug."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A2 | A3)",
            "(A2 -> -A1)",
            "(A3 -> -A1)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that a person approves a drug."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A49 | A50)",
            "(A49 -> -A48)",
            "(A50 -> -A48)"
          ],
          "conclusion": "-A48",
          "natural": "It is not the case that a financial firm has a regulatory exception for a financial product."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A8 -> -A9) -> A48)",
            "-A48"
          ],
          "conclusion": "(A8 -> -A9)",
          "natural": "Provided that a financial firm violates a regulation with a financial product, it does not face a fine for that product."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(A8 -> A9)",
            "(A8 -> -A9)"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that a financial firm violates a regulation with a financial product."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | G)",
            "-A8"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A52 | (A51 -> -A8))",
            "-A52"
          ],
          "conclusion": "(A51 -> -A8)",
          "natural": "If a person submits a whistleblower report about a financial firm, then that firm does not violate a regulation with a financial product."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A51 -> -A8)",
            "A51"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that a financial firm violates a regulation with a financial product."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | G)",
            "-A8"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 11,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A55 | A56)",
            "(A55 -> (A54 -> (A8 -> A53)))",
            "(A56 -> (A54 -> (A8 -> A53)))"
          ],
          "conclusion": "(A54 -> (A8 -> A53))",
          "natural": "Whenever a financial firm undergoes a compliance officer review for a financial product, then if the firm violates a regulation with that product, it takes corrective action for the product."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A54 -> (A8 -> A53))",
            "A54"
          ],
          "conclusion": "(A8 -> A53)",
          "natural": "In case a financial firm violates a regulation with a financial product, then it takes corrective action for that product."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(A8 -> A53)",
            "-A53"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that a financial firm violates a regulation with a financial product."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | G)",
            "-A8"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 12,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A60 -> A61) -> A62)",
            "-A62"
          ],
          "conclusion": "(A60 -> A61)",
          "natural": "Should a financial firm have an extended deadline for a financial product, then it is granted an extension for that product."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A60 -> A61)",
            "-A61"
          ],
          "conclusion": "-A60",
          "natural": "It is not the case that a financial firm has an extended deadline for a financial product."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A58 -> A59) -> A60)",
            "-A60"
          ],
          "conclusion": "(A58 -> A59)",
          "natural": "Provided that a financial firm makes a voluntary disclosure for a financial product, it makes a mandatory disclosure for that product."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A58 -> A59)",
            "(A59 -> A57)"
          ],
          "conclusion": "(A58 -> A57)",
          "natural": "If a financial firm makes a voluntary disclosure for a financial product, then it self-reports for that product."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A58)",
            "(A58 -> A57)"
          ],
          "conclusion": "(A8 -> A57)",
          "natural": "Provided that a financial firm violates a regulation with a financial product, it self-reports for that product."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A57)",
            "(A57 -> -A9)"
          ],
          "conclusion": "(A8 -> -A9)",
          "natural": "Provided that a financial firm violates a regulation with a financial product, it does not face a fine for that product."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(A8 -> A9)",
            "(A8 -> -A9)"
          ],
          "conclusion": "-A8",
          "natural": "It is not the case that a financial firm violates a regulation with a financial product."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | G)",
            "-A8"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 13,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A63 -> A65)",
            "(A65 -> (-(A13 | G) -> A14))"
          ],
          "conclusion": "(A63 -> (-(A13 | G) -> A14))",
          "natural": "In case a financial product is complex, then if the drug is not approved for sale and not a generic drug, the drug is for restricted use."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A63 | A64)",
            "(A63 -> (-(A13 | G) -> A14))",
            "(A64 -> (-(A13 | G) -> A14))"
          ],
          "conclusion": "(-(A13 | G) -> A14)",
          "natural": "In case the drug is not approved for sale and not a generic drug, then the drug is for restricted use."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A13 | G) -> A14)",
            "(-(A13 | G) -> -A14)"
          ],
          "conclusion": "(A13 | G)",
          "natural": "Either a drug is approved for sale or it is a generic drug."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A13 | G)",
            "-A13"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 14,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A70 | A71)",
            "(A70 -> (A68 | A69))",
            "(A71 -> (A68 | A69))"
          ],
          "conclusion": "(A68 | A69)",
          "natural": "A financial product either undergoes risk assessment or stress testing."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A68 | A69)",
            "(A68 -> (A67 -> A66))",
            "(A69 -> (A67 -> A66))"
          ],
          "conclusion": "(A67 -> A66)",
          "natural": "Provided that a financial product has leverage limits, it has capital requirements."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A67)",
            "(A67 -> A66)"
          ],
          "conclusion": "(A15 -> A66)",
          "natural": "If a financial product is high risk, then it has capital requirements."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A66)",
            "(A66 -> A17)"
          ],
          "conclusion": "(A15 -> A17)",
          "natural": "Whenever a financial product is high risk, it requires disclosure."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A17)",
            "(A17 -> (-(A13 | G) -> A14))"
          ],
          "conclusion": "(A15 -> (-(A13 | G) -> A14))",
          "natural": "In case a financial product is high risk, then if the drug is neither approved for sale nor a generic drug, the drug is for restricted use."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A15 | A16)",
            "(A15 -> (-(A13 | G) -> A14))",
            "(A16 -> (-(A13 | G) -> A14))"
          ],
          "conclusion": "(-(A13 | G) -> A14)",
          "natural": "In case the drug is not approved for sale and not a generic drug, then the drug is for restricted use."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A13 | G) -> A14)",
            "(-(A13 | G) -> -A14)"
          ],
          "conclusion": "(A13 | G)",
          "natural": "Either a drug is approved for sale or it is a generic drug."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A13 | G)",
            "-A13"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 15,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-(A13 | G) -> A14) -> A73) -> A74)",
            "(-(-(-(A13 | G) -> A14) -> A73) -> -A74)"
          ],
          "conclusion": "(-(-(A13 | G) -> A14) -> A73)",
          "natural": "In case it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, the drug receives conditional approval."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A13 | G) -> A14) -> A73)",
            "(A73 -> A72)"
          ],
          "conclusion": "(-(-(A13 | G) -> A14) -> A72)",
          "natural": "Provided that it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, the drug receives full approval."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A13 | G) -> A14) -> A72)",
            "-A72"
          ],
          "conclusion": "(-(A13 | G) -> A14)",
          "natural": "In case the drug is not approved for sale and not a generic drug, then the drug is for restricted use."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A13 | G) -> A14)",
            "(-(A13 | G) -> -A14)"
          ],
          "conclusion": "(A13 | G)",
          "natural": "Either a drug is approved for sale or it is a generic drug."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A13 | G)",
            "-A13"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    },
    {
      "id": 16,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A78 -> (A77 -> (A75 | A76)))",
            "A78"
          ],
          "conclusion": "(A77 -> (A75 | A76))",
          "natural": "Should a drug be in clinical research, then it is either in phase 1 trial or phase 2 trial."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A77 -> (A75 | A76))",
            "A77"
          ],
          "conclusion": "(A75 | A76)",
          "natural": "A drug is either in phase 1 trial or phase 2 trial."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A75 | A76)",
            "(A75 -> (A13 | G))",
            "(A76 -> (A13 | G))"
          ],
          "conclusion": "(A13 | G)",
          "natural": "Either a drug is approved for sale or it is a generic drug."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A13 | G)",
            "-A13"
          ],
          "conclusion": "G",
          "natural": "A drug is a generic drug."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Financial Regulation",
    "atomic_facts": {
      "A1": "approves(person, drug)",
      "A2": "investigates(agency, financial_product)",
      "A3": "bans(agency, financial_product)",
      "A4": "finds_risky(agency, financial_product)",
      "A5": "issues_warning(agency, financial_product)",
      "A6": "proposes_legislation(legislator, financial_product)",
      "A7": "amends_legislation(legislator, financial_product)",
      "A8": "violates_regulation(financial_firm, financial_product)",
      "A9": "faces_fine(financial_firm, financial_product)",
      "A10": "monitors(agency, financial_firm)",
      "A11": "audits(agency, financial_firm)",
      "A12": "investigates(agency, financial_firm)",
      "A13": "approved_for_sale(drug)",
      "A14": "restricted_use(drug)",
      "A15": "high_risk_product(financial_product)",
      "A16": "medium_risk_product(financial_product)",
      "A17": "requires_disclosure(financial_product)",
      "A18": "requires_licensing(financial_product)",
      "A19": "conflicting_policy(agency)",
      "A20": "supports_industry(agency)",
      "A21": "drafts_bill(legislator, financial_product)",
      "A22": "sponsors_bill(legislator, financial_product)",
      "A23": "safe_investment(financial_product)",
      "A24": "regulated_investment(financial_product)",
      "A25": "approved_fund(financial_product)",
      "A26": "restricted_fund(financial_product)",
      "A27": "established_fund(financial_product)",
      "A28": "new_fund(financial_product)",
      "A29": "domestic_fund(financial_product)",
      "A30": "foreign_fund(financial_product)",
      "A31": "hybrid_fund(financial_product)",
      "A32": "investment_product(financial_product)",
      "A33": "routine_inspection(agency, financial_product)",
      "A34": "emergency_action(agency, financial_product)",
      "A35": "normal_market_conditions(financial_product)",
      "A36": "volatile_market(financial_product)",
      "A37": "market_crash(financial_product)",
      "A38": "economic_stability(financial_product)",
      "A39": "growth_period(financial_product)",
      "A40": "boom_period(financial_product)",
      "A41": "initial_review(agency, financial_product)",
      "A42": "followup_review(agency, financial_product)",
      "A43": "compliant_product(financial_product)",
      "A44": "noncompliant_product(financial_product)",
      "A45": "minor_violation(financial_product)",
      "A46": "major_violation(financial_product)",
      "A47": "pending_investigation(financial_product)",
      "A48": "regulatory_exception(financial_firm, financial_product)",
      "A49": "standard_compliance(financial_firm, financial_product)",
      "A50": "enhanced_compliance(financial_firm, financial_product)",
      "A51": "whistleblower_report(person, financial_firm)",
      "A52": "internal_audit(financial_firm)",
      "A53": "corrective_action(financial_firm, financial_product)",
      "A54": "compliance_officer_review(financial_firm, financial_product)",
      "A55": "senior_approval(financial_firm, financial_product)",
      "A56": "committee_approval(financial_firm, financial_product)",
      "A57": "self_reporting(financial_firm, financial_product)",
      "A58": "voluntary_disclosure(financial_firm, financial_product)",
      "A59": "mandatory_disclosure(financial_firm, financial_product)",
      "A60": "extended_deadline(financial_firm, financial_product)",
      "A61": "granted_extension(financial_firm, financial_product)",
      "A62": "denied_extension(financial_firm, financial_product)",
      "A63": "complex_product(financial_product)",
      "A64": "simple_product(financial_product)",
      "A65": "structured_product(financial_product)",
      "A66": "capital_requirements(financial_product)",
      "A67": "leverage_limits(financial_product)",
      "A68": "risk_assessment(financial_product)",
      "A69": "stress_testing(financial_product)",
      "A70": "quarterly_review(financial_product)",
      "A71": "annual_review(financial_product)",
      "A72": "full_approval(drug)",
      "A73": "conditional_approval(drug)",
      "A74": "fast_track_approval(drug)",
      "A75": "phase1_trial(drug)",
      "A76": "phase2_trial(drug)",
      "A77": "clinical_research(drug)",
      "A78": "research_funding(drug)",
      "G": "generic_drug(drug)"
    },
    "natural_facts": {
      "A1": "A person approves a drug.",
      "A2": "An agency investigates a financial product.",
      "A3": "An agency bans a financial product.",
      "A4": "An agency finds a financial product risky.",
      "A5": "An agency issues a warning for a financial product.",
      "A6": "A legislator proposes legislation for a financial product.",
      "A7": "A legislator amends legislation for a financial product.",
      "A8": "A financial firm violates a regulation with a financial product.",
      "A9": "A financial firm faces a fine for a financial product.",
      "A10": "An agency monitors a financial firm.",
      "A11": "An agency audits a financial firm.",
      "A12": "An agency investigates a financial firm.",
      "A13": "A drug is approved for sale.",
      "A14": "A drug is for restricted use.",
      "A15": "A financial product is high risk.",
      "A16": "A financial product is medium risk.",
      "A17": "A financial product requires disclosure.",
      "A18": "A financial product requires licensing.",
      "A19": "An agency has conflicting policy.",
      "A20": "An agency supports the industry.",
      "A21": "A legislator drafts a bill for a financial product.",
      "A22": "A legislator sponsors a bill for a financial product.",
      "A23": "A financial product is a safe investment.",
      "A24": "A financial product is a regulated investment.",
      "A25": "A financial product is an approved fund.",
      "A26": "A financial product is a restricted fund.",
      "A27": "A financial product is an established fund.",
      "A28": "A financial product is a new fund.",
      "A29": "A financial product is a domestic fund.",
      "A30": "A financial product is a foreign fund.",
      "A31": "A financial product is a hybrid fund.",
      "A32": "A financial product is an investment product.",
      "A33": "An agency performs a routine inspection on a financial product.",
      "A34": "An agency takes emergency action on a financial product.",
      "A35": "A financial product is under normal market conditions.",
      "A36": "A financial product is in a volatile market.",
      "A37": "A financial product experiences a market crash.",
      "A38": "A financial product contributes to economic stability.",
      "A39": "A financial product is in a growth period.",
      "A40": "A financial product is in a boom period.",
      "A41": "An agency conducts an initial review of a financial product.",
      "A42": "An agency conducts a followup review of a financial product.",
      "A43": "A financial product is compliant.",
      "A44": "A financial product is noncompliant.",
      "A45": "A financial product has a minor violation.",
      "A46": "A financial product has a major violation.",
      "A47": "A financial product is under pending investigation.",
      "A48": "A financial firm has a regulatory exception for a financial product.",
      "A49": "A financial firm follows standard compliance for a financial product.",
      "A50": "A financial firm follows enhanced compliance for a financial product.",
      "A51": "A person submits a whistleblower report about a financial firm.",
      "A52": "A financial firm conducts an internal audit.",
      "A53": "A financial firm takes corrective action for a financial product.",
      "A54": "A financial firm undergoes a compliance officer review for a financial product.",
      "A55": "A financial firm obtains senior approval for a financial product.",
      "A56": "A financial firm obtains committee approval for a financial product.",
      "A57": "A financial firm self-reports for a financial product.",
      "A58": "A financial firm makes a voluntary disclosure for a financial product.",
      "A59": "A financial firm makes a mandatory disclosure for a financial product.",
      "A60": "A financial firm has an extended deadline for a financial product.",
      "A61": "A financial firm is granted an extension for a financial product.",
      "A62": "A financial firm is denied an extension for a financial product.",
      "A63": "A financial product is complex.",
      "A64": "A financial product is simple.",
      "A65": "A financial product is structured.",
      "A66": "A financial product has capital requirements.",
      "A67": "A financial product has leverage limits.",
      "A68": "A financial product undergoes risk assessment.",
      "A69": "A financial product undergoes stress testing.",
      "A70": "A financial product has a quarterly review.",
      "A71": "A financial product has an annual review.",
      "A72": "A drug receives full approval.",
      "A73": "A drug receives conditional approval.",
      "A74": "A drug receives fast-track approval.",
      "A75": "A drug is in phase 1 trial.",
      "A76": "A drug is in phase 2 trial.",
      "A77": "A drug is in clinical research.",
      "A78": "A drug receives research funding.",
      "G": "A drug is a generic drug."
    },
    "prover9_expressions": [
      "(approves(person, drug) | generic_drug(drug))",
      "(monitors(agency, financial_firm) -> (violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product)))",
      "(investigates(agency, financial_firm) -> audits(agency, financial_firm))",
      "(approved_for_sale(drug) | generic_drug(drug))",
      "(high_risk_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
      "(high_risk_product(financial_product) -> requires_disclosure(financial_product))",
      "(high_risk_product(financial_product) -> requires_licensing(financial_product))",
      "(high_risk_product(financial_product) -> capital_requirements(financial_product))",
      "(high_risk_product(financial_product) -> leverage_limits(financial_product))",
      "(high_risk_product(financial_product) | medium_risk_product(financial_product))",
      "(medium_risk_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
      "(requires_disclosure(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
      "(requires_licensing(financial_product) -> requires_disclosure(financial_product))",
      "(conflicting_policy(agency) -> supports_industry(agency))",
      "(conflicting_policy(agency) -> -supports_industry(agency))",
      "(conflicting_policy(agency) | (proposes_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product))))",
      "(investigates(agency, financial_product) -> finds_risky(agency, financial_product))",
      "(investigates(agency, financial_product) -> -approves(person, drug))",
      "(investigates(agency, financial_product) | bans(agency, financial_product))",
      "(drafts_bill(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
      "(drafts_bill(legislator, financial_product) -> sponsors_bill(legislator, financial_product))",
      "(sponsors_bill(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
      "(safe_investment(financial_product) | -approves(person, drug))",
      "(regulated_investment(financial_product) | -safe_investment(financial_product))",
      "(approved_fund(financial_product) -> regulated_investment(financial_product))",
      "(approved_fund(financial_product) | restricted_fund(financial_product))",
      "(restricted_fund(financial_product) -> -safe_investment(financial_product))",
      "(established_fund(financial_product) -> approved_fund(financial_product))",
      "(established_fund(financial_product) | new_fund(financial_product))",
      "(new_fund(financial_product) -> restricted_fund(financial_product))",
      "(domestic_fund(financial_product) -> established_fund(financial_product))",
      "(domestic_fund(financial_product) | foreign_fund(financial_product))",
      "(bans(agency, financial_product) -> -approves(person, drug))",
      "(foreign_fund(financial_product) -> new_fund(financial_product))",
      "(hybrid_fund(financial_product) | (domestic_fund(financial_product) | foreign_fund(financial_product)))",
      "(investment_product(financial_product) -> (hybrid_fund(financial_product) | (domestic_fund(financial_product) | foreign_fund(financial_product))))",
      "(routine_inspection(agency, financial_product) -> (investigates(agency, financial_product) -> finds_risky(agency, financial_product)))",
      "(normal_market_conditions(financial_product) -> -emergency_action(agency, financial_product))",
      "(economic_stability(financial_product) -> -market_crash(financial_product))",
      "(finds_risky(agency, financial_product) -> -approves(person, drug))",
      "(boom_period(financial_product) -> growth_period(financial_product))",
      "(initial_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug)))",
      "(initial_review(agency, financial_product) | followup_review(agency, financial_product))",
      "(followup_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug)))",
      "(compliant_product(financial_product) | (followup_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug))))",
      "(noncompliant_product(financial_product) | -compliant_product(financial_product))",
      "(major_violation(financial_product) -> minor_violation(financial_product))",
      "(pending_investigation(financial_product) | (-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> major_violation(financial_product)))",
      "(standard_compliance(financial_firm, financial_product) -> -regulatory_exception(financial_firm, financial_product))",
      "(standard_compliance(financial_firm, financial_product) | enhanced_compliance(financial_firm, financial_product))",
      "(enhanced_compliance(financial_firm, financial_product) -> -regulatory_exception(financial_firm, financial_product))",
      "(whistleblower_report(person, financial_firm) -> -violates_regulation(financial_firm, financial_product))",
      "(internal_audit(financial_firm) | (whistleblower_report(person, financial_firm) -> -violates_regulation(financial_firm, financial_product)))",
      "(compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product)))",
      "(senior_approval(financial_firm, financial_product) -> (compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))))",
      "(senior_approval(financial_firm, financial_product) | committee_approval(financial_firm, financial_product))",
      "(committee_approval(financial_firm, financial_product) -> (compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))))",
      "(self_reporting(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product))",
      "(voluntary_disclosure(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
      "(voluntary_disclosure(financial_firm, financial_product) -> mandatory_disclosure(financial_firm, financial_product))",
      "(mandatory_disclosure(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
      "(proposes_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
      "(proposes_legislation(legislator, financial_product) -> drafts_bill(legislator, financial_product))",
      "(proposes_legislation(legislator, financial_product) -> amends_legislation(legislator, financial_product))",
      "(extended_deadline(financial_firm, financial_product) -> granted_extension(financial_firm, financial_product))",
      "(complex_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
      "(complex_product(financial_product) -> structured_product(financial_product))",
      "(complex_product(financial_product) | simple_product(financial_product))",
      "(simple_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
      "(structured_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
      "(capital_requirements(financial_product) -> requires_disclosure(financial_product))",
      "(leverage_limits(financial_product) -> capital_requirements(financial_product))",
      "(risk_assessment(financial_product) -> (leverage_limits(financial_product) -> capital_requirements(financial_product)))",
      "(risk_assessment(financial_product) | stress_testing(financial_product))",
      "(stress_testing(financial_product) -> (leverage_limits(financial_product) -> capital_requirements(financial_product)))",
      "(amends_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
      "(quarterly_review(financial_product) -> (risk_assessment(financial_product) | stress_testing(financial_product)))",
      "(quarterly_review(financial_product) | annual_review(financial_product))",
      "(annual_review(financial_product) -> (risk_assessment(financial_product) | stress_testing(financial_product)))",
      "(conditional_approval(drug) -> full_approval(drug))",
      "(phase1_trial(drug) -> (approved_for_sale(drug) | generic_drug(drug)))",
      "(phase1_trial(drug) | phase2_trial(drug))",
      "(phase2_trial(drug) -> (approved_for_sale(drug) | generic_drug(drug)))",
      "(clinical_research(drug) -> (phase1_trial(drug) | phase2_trial(drug)))",
      "(research_funding(drug) -> (clinical_research(drug) -> (phase1_trial(drug) | phase2_trial(drug))))",
      "(violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))",
      "(violates_regulation(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
      "(violates_regulation(financial_firm, financial_product) -> voluntary_disclosure(financial_firm, financial_product))",
      "(violates_regulation(financial_firm, financial_product) -> faces_fine(financial_firm, financial_product))",
      "(violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product))",
      "(violates_regulation(financial_firm, financial_product) | generic_drug(drug))",
      "(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug))",
      "(-(approved_for_sale(drug) | generic_drug(drug)) -> -restricted_use(drug))",
      "(-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product))",
      "(-(routine_inspection(agency, financial_product) -> (investigates(agency, financial_product) -> finds_risky(agency, financial_product))) -> emergency_action(agency, financial_product))",
      "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> minor_violation(financial_product))",
      "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> major_violation(financial_product))",
      "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> -minor_violation(financial_product))",
      "(-(voluntary_disclosure(financial_firm, financial_product) -> mandatory_disclosure(financial_firm, financial_product)) -> extended_deadline(financial_firm, financial_product))",
      "(-(extended_deadline(financial_firm, financial_product) -> granted_extension(financial_firm, financial_product)) -> denied_extension(financial_firm, financial_product))",
      "(-(violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product)) -> regulatory_exception(financial_firm, financial_product))",
      "(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> full_approval(drug))",
      "(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug))",
      "(-(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug)) -> fast_track_approval(drug))",
      "(-(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug)) -> -fast_track_approval(drug))",
      "(-(-normal_market_conditions(financial_product) -> volatile_market(financial_product)) -> market_crash(financial_product))",
      "(-monitors(agency, financial_firm) -> audits(agency, financial_firm))",
      "(-monitors(agency, financial_firm) -> investigates(agency, financial_firm))",
      "(-normal_market_conditions(financial_product) -> volatile_market(financial_product))",
      "(-economic_stability(financial_product) -> growth_period(financial_product))",
      "(-economic_stability(financial_product) -> boom_period(financial_product))",
      "monitors(agency, financial_firm)",
      "investment_product(financial_product)",
      "routine_inspection(agency, financial_product)",
      "normal_market_conditions(financial_product)",
      "economic_stability(financial_product)",
      "whistleblower_report(person, financial_firm)",
      "compliance_officer_review(financial_firm, financial_product)",
      "proposes_legislation(legislator, financial_product)",
      "clinical_research(drug)",
      "research_funding(drug)",
      "generic_drug(drug)",
      "-approves(person, drug)",
      "-audits(agency, financial_firm)",
      "-approved_for_sale(drug)",
      "-conflicting_policy(agency)",
      "-safe_investment(financial_product)",
      "-regulated_investment(financial_product)",
      "-hybrid_fund(financial_product)",
      "-emergency_action(agency, financial_product)",
      "-volatile_market(financial_product)",
      "-market_crash(financial_product)",
      "-growth_period(financial_product)",
      "-compliant_product(financial_product)",
      "-noncompliant_product(financial_product)",
      "-pending_investigation(financial_product)",
      "-regulatory_exception(financial_firm, financial_product)",
      "-issues_warning(agency, financial_product)",
      "-internal_audit(financial_firm)",
      "-corrective_action(financial_firm, financial_product)",
      "-extended_deadline(financial_firm, financial_product)",
      "-granted_extension(financial_firm, financial_product)",
      "-denied_extension(financial_firm, financial_product)",
      "-full_approval(drug)",
      "-violates_regulation(financial_firm, financial_product)"
    ],
    "natural_expressions": [
      "Either a person approves a drug or the drug is a generic drug.",
      "If an agency monitors a financial firm, then whenever that firm violates a regulation with a financial product, it does not face a fine for that product.",
      "Provided that an agency investigates a financial firm, it also audits that firm.",
      "Either a drug is approved for sale or it is a generic drug.",
      "In case a financial product is high risk, then if the drug is neither approved for sale nor a generic drug, the drug is for restricted use.",
      "Whenever a financial product is high risk, it requires disclosure.",
      "Should a financial product be high risk, it requires licensing.",
      "If a financial product is high risk, then it has capital requirements.",
      "Given that a financial product is high risk, it has leverage limits.",
      "A financial product is either high risk or medium risk.",
      "Assuming a financial product is medium risk, then provided that the drug is not approved for sale and not a generic drug, the drug is for restricted use.",
      "If a financial product requires disclosure, then in the event that the drug is not approved for sale and not a generic drug, the drug is for restricted use.",
      "Provided that a financial product requires licensing, it also requires disclosure.",
      "Whenever an agency has conflicting policy, it supports the industry.",
      "In case an agency has conflicting policy, it does not support the industry.",
      "Either an agency has conflicting policy, or if a legislator proposes legislation for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product.",
      "If an agency investigates a financial product, then it finds that product risky.",
      "Provided that an agency investigates a financial product, a person does not approve a drug.",
      "An agency either investigates a financial product or bans that product.",
      "Should a legislator draft a bill for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product.",
      "If a legislator drafts a bill for a financial product, then that legislator sponsors the bill for the product.",
      "Provided that a legislator sponsors a bill for a financial product, then in case the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product.",
      "Either a financial product is a safe investment or a person does not approve a drug.",
      "A financial product is a regulated investment or it is not a safe investment.",
      "If a financial product is an approved fund, then it is a regulated investment.",
      "A financial product is either an approved fund or a restricted fund.",
      "Provided that a financial product is a restricted fund, it is not a safe investment.",
      "In case a financial product is an established fund, it is an approved fund.",
      "A financial product is either an established fund or a new fund.",
      "Should a financial product be a new fund, then it is a restricted fund.",
      "If a financial product is a domestic fund, then it is an established fund.",
      "A financial product is either a domestic fund or a foreign fund.",
      "Provided that an agency bans a financial product, a person does not approve a drug.",
      "In case a financial product is a foreign fund, then it is a new fund.",
      "A financial product is a hybrid fund, or it is either a domestic fund or a foreign fund.",
      "If a financial product is an investment product, then it is either a hybrid fund, or a domestic fund, or a foreign fund.",
      "Whenever an agency performs a routine inspection on a financial product, then if it investigates that product, it finds the product risky.",
      "Provided that a financial product is under normal market conditions, the agency does not take emergency action on that product.",
      "In case a financial product contributes to economic stability, it does not experience a market crash.",
      "Should an agency find a financial product risky, then a person does not approve a drug.",
      "If a financial product is in a boom period, then it is in a growth period.",
      "Whenever an agency conducts an initial review of a financial product, then if it investigates that product, a person does not approve a drug.",
      "An agency either conducts an initial review of a financial product or a followup review of that product.",
      "Provided that an agency conducts a followup review of a financial product, then if it investigates that product, a person does not approve a drug.",
      "Either a financial product is compliant, or if the agency conducts a followup review of the product, then whenever it investigates the product, a person does not approve a drug.",
      "A financial product is noncompliant or it is not compliant.",
      "In case a financial product has a major violation, then it has a minor violation.",
      "A financial product is under pending investigation, or if the product is not noncompliant and not compliant, then it has a major violation.",
      "Should a financial firm follow standard compliance for a financial product, then it does not have a regulatory exception for that product.",
      "A financial firm either follows standard compliance for a financial product or enhanced compliance for that product.",
      "Provided that a financial firm follows enhanced compliance for a financial product, it does not have a regulatory exception for that product.",
      "If a person submits a whistleblower report about a financial firm, then that firm does not violate a regulation with a financial product.",
      "Either a financial firm conducts an internal audit, or if a person submits a whistleblower report about the firm, then the firm does not violate a regulation with a financial product.",
      "Whenever a financial firm undergoes a compliance officer review for a financial product, then if the firm violates a regulation with that product, it takes corrective action for the product.",
      "Provided that a financial firm obtains senior approval for a financial product, then if it undergoes a compliance officer review for the product, and the firm violates a regulation with the product, it takes corrective action for the product.",
      "A financial firm either obtains senior approval for a financial product or committee approval for that product.",
      "In case a financial firm obtains committee approval for a financial product, then if it undergoes a compliance officer review for the product, and the firm violates a regulation with the product, it takes corrective action for the product.",
      "Should a financial firm self-report for a financial product, then it does not face a fine for that product.",
      "If a financial firm makes a voluntary disclosure for a financial product, then it self-reports for that product.",
      "Provided that a financial firm makes a voluntary disclosure for a financial product, it makes a mandatory disclosure for that product.",
      "In case a financial firm makes a mandatory disclosure for a financial product, then it self-reports for that product.",
      "Whenever a legislator proposes legislation for a financial product, then if the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product.",
      "If a legislator proposes legislation for a financial product, then that legislator drafts a bill for the product.",
      "Provided that a legislator proposes legislation for a financial product, then that legislator amends legislation for the product.",
      "Should a financial firm have an extended deadline for a financial product, then it is granted an extension for that product.",
      "In case a financial product is complex, then if the drug is not approved for sale and not a generic drug, the drug is for restricted use.",
      "If a financial product is complex, then it is structured.",
      "A financial product is either complex or simple.",
      "Provided that a financial product is simple, then whenever the drug is not approved for sale and not a generic drug, the drug is for restricted use.",
      "Should a financial product be structured, then in the event that the drug is not approved for sale and not a generic drug, the drug is for restricted use.",
      "If a financial product has capital requirements, then it requires disclosure.",
      "Provided that a financial product has leverage limits, it has capital requirements.",
      "Whenever a financial product undergoes risk assessment, then if it has leverage limits, it has capital requirements.",
      "A financial product either undergoes risk assessment or stress testing.",
      "In case a financial product undergoes stress testing, then provided that it has leverage limits, it has capital requirements.",
      "Should a legislator amend legislation for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product.",
      "If a financial product has a quarterly review, then it either undergoes risk assessment or stress testing.",
      "A financial product either has a quarterly review or an annual review.",
      "Provided that a financial product has an annual review, then it either undergoes risk assessment or stress testing.",
      "In case a drug receives conditional approval, then it receives full approval.",
      "If a drug is in phase 1 trial, then it is either approved for sale or a generic drug.",
      "A drug is either in phase 1 trial or phase 2 trial.",
      "Provided that a drug is in phase 2 trial, then it is either approved for sale or a generic drug.",
      "Should a drug be in clinical research, then it is either in phase 1 trial or phase 2 trial.",
      "If a drug receives research funding, then whenever it is in clinical research, it is either in phase 1 trial or phase 2 trial.",
      "In case a financial firm violates a regulation with a financial product, then it takes corrective action for that product.",
      "Provided that a financial firm violates a regulation with a financial product, it self-reports for that product.",
      "Should a financial firm violate a regulation with a financial product, it makes a voluntary disclosure for that product.",
      "If a financial firm violates a regulation with a financial product, then it faces a fine for that product.",
      "Provided that a financial firm violates a regulation with a financial product, it does not face a fine for that product.",
      "Either a financial firm violates a regulation with a financial product or a drug is a generic drug.",
      "In case the drug is not approved for sale and not a generic drug, then the drug is for restricted use.",
      "Should the drug not be approved for sale and not be a generic drug, then it is not for restricted use.",
      "Whenever the agency does not investigate a financial product, and it finds the product risky, the agency issues a warning for the product.",
      "Provided that it is not the case that if the agency performs a routine inspection on a financial product, then if it investigates that product, it finds the product risky, the agency takes emergency action on that product.",
      "In case the financial product is not noncompliant and not compliant, then it has a minor violation.",
      "Should the financial product not be noncompliant and not be compliant, then it has a major violation.",
      "Provided that the financial product is not noncompliant and not compliant, it does not have a minor violation.",
      "Whenever it is not the case that if a financial firm makes a voluntary disclosure for a financial product, then it makes a mandatory disclosure for that product, the firm has an extended deadline for the product.",
      "In case it is not the case that if a financial firm has an extended deadline for a financial product, then it is granted an extension for that product, the firm is denied an extension for the product.",
      "Should it not be the case that if a financial firm violates a regulation with a financial product, then it does not face a fine for that product, the firm has a regulatory exception for the product.",
      "Provided that it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, the drug receives full approval.",
      "In case it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, the drug receives conditional approval.",
      "Should it not be the case that if it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, then the drug receives conditional approval, the drug receives fast-track approval.",
      "Provided that it is not the case that if it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, then the drug receives conditional approval, the drug does not receive fast-track approval.",
      "In case it is not the case that if the financial product is not under normal market conditions, then it is in a volatile market, the product experiences a market crash.",
      "Should an agency not monitor a financial firm, then it audits that firm.",
      "Provided that an agency does not monitor a financial firm, it investigates that firm.",
      "If a financial product is not under normal market conditions, then it is in a volatile market.",
      "In case a financial product does not contribute to economic stability, then it is in a growth period.",
      "Provided that a financial product does not contribute to economic stability, it is in a boom period.",
      "An agency monitors a financial firm.",
      "A financial product is an investment product.",
      "An agency performs a routine inspection on a financial product.",
      "A financial product is under normal market conditions.",
      "A financial product contributes to economic stability.",
      "A person submits a whistleblower report about a financial firm.",
      "A financial firm undergoes a compliance officer review for a financial product.",
      "A legislator proposes legislation for a financial product.",
      "A drug is in clinical research.",
      "A drug receives research funding.",
      "A drug is a generic drug.",
      "It is not the case that a person approves a drug.",
      "It is not the case that an agency audits a financial firm.",
      "It is not the case that a drug is approved for sale.",
      "It is not the case that an agency has conflicting policy.",
      "It is not the case that a financial product is a safe investment.",
      "It is not the case that a financial product is a regulated investment.",
      "It is not the case that a financial product is a hybrid fund.",
      "It is not the case that an agency takes emergency action on a financial product.",
      "It is not the case that a financial product is in a volatile market.",
      "It is not the case that a financial product experiences a market crash.",
      "It is not the case that a financial product is in a growth period.",
      "It is not the case that a financial product is compliant.",
      "It is not the case that a financial product is noncompliant.",
      "It is not the case that a financial product is under pending investigation.",
      "It is not the case that a financial firm has a regulatory exception for a financial product.",
      "It is not the case that an agency issues a warning for a financial product.",
      "It is not the case that a financial firm conducts an internal audit.",
      "It is not the case that a financial firm takes corrective action for a financial product.",
      "It is not the case that a financial firm has an extended deadline for a financial product.",
      "It is not the case that a financial firm is granted an extension for a financial product.",
      "It is not the case that a financial firm is denied an extension for a financial product.",
      "It is not the case that a drug receives full approval.",
      "It is not the case that a financial firm violates a regulation with a financial product."
    ],
    "node_mappings": {
      "(A1 ∨ G)": {
        "formal": "(A1 ∨ G)",
        "prover9": "(A1 | G)",
        "prover9_expression": "(approves(person, drug) | generic_drug(drug))",
        "natural": "Either a person approves a drug or the drug is a generic drug."
      },
      "(A10 → (A8 → ¬A9))": {
        "formal": "(A10 → (A8 → ¬A9))",
        "prover9": "(A10 -> (A8 -> -A9))",
        "prover9_expression": "(monitors(agency, financial_firm) -> (violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product)))",
        "natural": "If an agency monitors a financial firm, then whenever that firm violates a regulation with a financial product, it does not face a fine for that product."
      },
      "(A12 → A11)": {
        "formal": "(A12 → A11)",
        "prover9": "(A12 -> A11)",
        "prover9_expression": "(investigates(agency, financial_firm) -> audits(agency, financial_firm))",
        "natural": "Provided that an agency investigates a financial firm, it also audits that firm."
      },
      "(A13 ∨ G)": {
        "formal": "(A13 ∨ G)",
        "prover9": "(A13 | G)",
        "prover9_expression": "(approved_for_sale(drug) | generic_drug(drug))",
        "natural": "Either a drug is approved for sale or it is a generic drug."
      },
      "(A15 → (¬(A13 ∨ G) → A14))": {
        "formal": "(A15 → (¬(A13 ∨ G) → A14))",
        "prover9": "(A15 -> (-(A13 | G) -> A14))",
        "prover9_expression": "(high_risk_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "In case a financial product is high risk, then if the drug is neither approved for sale nor a generic drug, the drug is for restricted use."
      },
      "(A15 → A17)": {
        "formal": "(A15 → A17)",
        "prover9": "(A15 -> A17)",
        "prover9_expression": "(high_risk_product(financial_product) -> requires_disclosure(financial_product))",
        "natural": "Whenever a financial product is high risk, it requires disclosure."
      },
      "(A15 → A18)": {
        "formal": "(A15 → A18)",
        "prover9": "(A15 -> A18)",
        "prover9_expression": "(high_risk_product(financial_product) -> requires_licensing(financial_product))",
        "natural": "Should a financial product be high risk, it requires licensing."
      },
      "(A15 → A66)": {
        "formal": "(A15 → A66)",
        "prover9": "(A15 -> A66)",
        "prover9_expression": "(high_risk_product(financial_product) -> capital_requirements(financial_product))",
        "natural": "If a financial product is high risk, then it has capital requirements."
      },
      "(A15 → A67)": {
        "formal": "(A15 → A67)",
        "prover9": "(A15 -> A67)",
        "prover9_expression": "(high_risk_product(financial_product) -> leverage_limits(financial_product))",
        "natural": "Given that a financial product is high risk, it has leverage limits."
      },
      "(A15 ∨ A16)": {
        "formal": "(A15 ∨ A16)",
        "prover9": "(A15 | A16)",
        "prover9_expression": "(high_risk_product(financial_product) | medium_risk_product(financial_product))",
        "natural": "A financial product is either high risk or medium risk."
      },
      "(A16 → (¬(A13 ∨ G) → A14))": {
        "formal": "(A16 → (¬(A13 ∨ G) → A14))",
        "prover9": "(A16 -> (-(A13 | G) -> A14))",
        "prover9_expression": "(medium_risk_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "Assuming a financial product is medium risk, then provided that the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      "(A17 → (¬(A13 ∨ G) → A14))": {
        "formal": "(A17 → (¬(A13 ∨ G) → A14))",
        "prover9": "(A17 -> (-(A13 | G) -> A14))",
        "prover9_expression": "(requires_disclosure(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "If a financial product requires disclosure, then in the event that the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      "(A18 → A17)": {
        "formal": "(A18 → A17)",
        "prover9": "(A18 -> A17)",
        "prover9_expression": "(requires_licensing(financial_product) -> requires_disclosure(financial_product))",
        "natural": "Provided that a financial product requires licensing, it also requires disclosure."
      },
      "(A19 → A20)": {
        "formal": "(A19 → A20)",
        "prover9": "(A19 -> A20)",
        "prover9_expression": "(conflicting_policy(agency) -> supports_industry(agency))",
        "natural": "Whenever an agency has conflicting policy, it supports the industry."
      },
      "(A19 → ¬A20)": {
        "formal": "(A19 → ¬A20)",
        "prover9": "(A19 -> -A20)",
        "prover9_expression": "(conflicting_policy(agency) -> -supports_industry(agency))",
        "natural": "In case an agency has conflicting policy, it does not support the industry."
      },
      "(A19 ∨ (A6 → (¬(A2 → A4) → A5)))": {
        "formal": "(A19 ∨ (A6 → (¬(A2 → A4) → A5)))",
        "prover9": "(A19 | (A6 -> (-(A2 -> A4) -> A5)))",
        "prover9_expression": "(conflicting_policy(agency) | (proposes_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product))))",
        "natural": "Either an agency has conflicting policy, or if a legislator proposes legislation for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      "(A2 → A4)": {
        "formal": "(A2 → A4)",
        "prover9": "(A2 -> A4)",
        "prover9_expression": "(investigates(agency, financial_product) -> finds_risky(agency, financial_product))",
        "natural": "If an agency investigates a financial product, then it finds that product risky."
      },
      "(A2 → ¬A1)": {
        "formal": "(A2 → ¬A1)",
        "prover9": "(A2 -> -A1)",
        "prover9_expression": "(investigates(agency, financial_product) -> -approves(person, drug))",
        "natural": "Provided that an agency investigates a financial product, a person does not approve a drug."
      },
      "(A2 ∨ A3)": {
        "formal": "(A2 ∨ A3)",
        "prover9": "(A2 | A3)",
        "prover9_expression": "(investigates(agency, financial_product) | bans(agency, financial_product))",
        "natural": "An agency either investigates a financial product or bans that product."
      },
      "(A21 → (¬(A2 → A4) → A5))": {
        "formal": "(A21 → (¬(A2 → A4) → A5))",
        "prover9": "(A21 -> (-(A2 -> A4) -> A5))",
        "prover9_expression": "(drafts_bill(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
        "natural": "Should a legislator draft a bill for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      "(A21 → A22)": {
        "formal": "(A21 → A22)",
        "prover9": "(A21 -> A22)",
        "prover9_expression": "(drafts_bill(legislator, financial_product) -> sponsors_bill(legislator, financial_product))",
        "natural": "If a legislator drafts a bill for a financial product, then that legislator sponsors the bill for the product."
      },
      "(A22 → (¬(A2 → A4) → A5))": {
        "formal": "(A22 → (¬(A2 → A4) → A5))",
        "prover9": "(A22 -> (-(A2 -> A4) -> A5))",
        "prover9_expression": "(sponsors_bill(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
        "natural": "Provided that a legislator sponsors a bill for a financial product, then in case the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      "(A23 ∨ ¬A1)": {
        "formal": "(A23 ∨ ¬A1)",
        "prover9": "(A23 | -A1)",
        "prover9_expression": "(safe_investment(financial_product) | -approves(person, drug))",
        "natural": "Either a financial product is a safe investment or a person does not approve a drug."
      },
      "(A24 ∨ ¬A23)": {
        "formal": "(A24 ∨ ¬A23)",
        "prover9": "(A24 | -A23)",
        "prover9_expression": "(regulated_investment(financial_product) | -safe_investment(financial_product))",
        "natural": "A financial product is a regulated investment or it is not a safe investment."
      },
      "(A25 → A24)": {
        "formal": "(A25 → A24)",
        "prover9": "(A25 -> A24)",
        "prover9_expression": "(approved_fund(financial_product) -> regulated_investment(financial_product))",
        "natural": "If a financial product is an approved fund, then it is a regulated investment."
      },
      "(A25 ∨ A26)": {
        "formal": "(A25 ∨ A26)",
        "prover9": "(A25 | A26)",
        "prover9_expression": "(approved_fund(financial_product) | restricted_fund(financial_product))",
        "natural": "A financial product is either an approved fund or a restricted fund."
      },
      "(A26 → ¬A23)": {
        "formal": "(A26 → ¬A23)",
        "prover9": "(A26 -> -A23)",
        "prover9_expression": "(restricted_fund(financial_product) -> -safe_investment(financial_product))",
        "natural": "Provided that a financial product is a restricted fund, it is not a safe investment."
      },
      "(A27 → A25)": {
        "formal": "(A27 → A25)",
        "prover9": "(A27 -> A25)",
        "prover9_expression": "(established_fund(financial_product) -> approved_fund(financial_product))",
        "natural": "In case a financial product is an established fund, it is an approved fund."
      },
      "(A27 ∨ A28)": {
        "formal": "(A27 ∨ A28)",
        "prover9": "(A27 | A28)",
        "prover9_expression": "(established_fund(financial_product) | new_fund(financial_product))",
        "natural": "A financial product is either an established fund or a new fund."
      },
      "(A28 → A26)": {
        "formal": "(A28 → A26)",
        "prover9": "(A28 -> A26)",
        "prover9_expression": "(new_fund(financial_product) -> restricted_fund(financial_product))",
        "natural": "Should a financial product be a new fund, then it is a restricted fund."
      },
      "(A29 → A27)": {
        "formal": "(A29 → A27)",
        "prover9": "(A29 -> A27)",
        "prover9_expression": "(domestic_fund(financial_product) -> established_fund(financial_product))",
        "natural": "If a financial product is a domestic fund, then it is an established fund."
      },
      "(A29 ∨ A30)": {
        "formal": "(A29 ∨ A30)",
        "prover9": "(A29 | A30)",
        "prover9_expression": "(domestic_fund(financial_product) | foreign_fund(financial_product))",
        "natural": "A financial product is either a domestic fund or a foreign fund."
      },
      "(A3 → ¬A1)": {
        "formal": "(A3 → ¬A1)",
        "prover9": "(A3 -> -A1)",
        "prover9_expression": "(bans(agency, financial_product) -> -approves(person, drug))",
        "natural": "Provided that an agency bans a financial product, a person does not approve a drug."
      },
      "(A30 → A28)": {
        "formal": "(A30 → A28)",
        "prover9": "(A30 -> A28)",
        "prover9_expression": "(foreign_fund(financial_product) -> new_fund(financial_product))",
        "natural": "In case a financial product is a foreign fund, then it is a new fund."
      },
      "(A31 ∨ (A29 ∨ A30))": {
        "formal": "(A31 ∨ (A29 ∨ A30))",
        "prover9": "(A31 | (A29 | A30))",
        "prover9_expression": "(hybrid_fund(financial_product) | (domestic_fund(financial_product) | foreign_fund(financial_product)))",
        "natural": "A financial product is a hybrid fund, or it is either a domestic fund or a foreign fund."
      },
      "(A32 → (A31 ∨ (A29 ∨ A30)))": {
        "formal": "(A32 → (A31 ∨ (A29 ∨ A30)))",
        "prover9": "(A32 -> (A31 | (A29 | A30)))",
        "prover9_expression": "(investment_product(financial_product) -> (hybrid_fund(financial_product) | (domestic_fund(financial_product) | foreign_fund(financial_product))))",
        "natural": "If a financial product is an investment product, then it is either a hybrid fund, or a domestic fund, or a foreign fund."
      },
      "(A33 → (A2 → A4))": {
        "formal": "(A33 → (A2 → A4))",
        "prover9": "(A33 -> (A2 -> A4))",
        "prover9_expression": "(routine_inspection(agency, financial_product) -> (investigates(agency, financial_product) -> finds_risky(agency, financial_product)))",
        "natural": "Whenever an agency performs a routine inspection on a financial product, then if it investigates that product, it finds the product risky."
      },
      "(A35 → ¬A34)": {
        "formal": "(A35 → ¬A34)",
        "prover9": "(A35 -> -A34)",
        "prover9_expression": "(normal_market_conditions(financial_product) -> -emergency_action(agency, financial_product))",
        "natural": "Provided that a financial product is under normal market conditions, the agency does not take emergency action on that product."
      },
      "(A38 → ¬A37)": {
        "formal": "(A38 → ¬A37)",
        "prover9": "(A38 -> -A37)",
        "prover9_expression": "(economic_stability(financial_product) -> -market_crash(financial_product))",
        "natural": "In case a financial product contributes to economic stability, it does not experience a market crash."
      },
      "(A4 → ¬A1)": {
        "formal": "(A4 → ¬A1)",
        "prover9": "(A4 -> -A1)",
        "prover9_expression": "(finds_risky(agency, financial_product) -> -approves(person, drug))",
        "natural": "Should an agency find a financial product risky, then a person does not approve a drug."
      },
      "(A40 → A39)": {
        "formal": "(A40 → A39)",
        "prover9": "(A40 -> A39)",
        "prover9_expression": "(boom_period(financial_product) -> growth_period(financial_product))",
        "natural": "If a financial product is in a boom period, then it is in a growth period."
      },
      "(A41 → (A2 → ¬A1))": {
        "formal": "(A41 → (A2 → ¬A1))",
        "prover9": "(A41 -> (A2 -> -A1))",
        "prover9_expression": "(initial_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug)))",
        "natural": "Whenever an agency conducts an initial review of a financial product, then if it investigates that product, a person does not approve a drug."
      },
      "(A41 ∨ A42)": {
        "formal": "(A41 ∨ A42)",
        "prover9": "(A41 | A42)",
        "prover9_expression": "(initial_review(agency, financial_product) | followup_review(agency, financial_product))",
        "natural": "An agency either conducts an initial review of a financial product or a followup review of that product."
      },
      "(A42 → (A2 → ¬A1))": {
        "formal": "(A42 → (A2 → ¬A1))",
        "prover9": "(A42 -> (A2 -> -A1))",
        "prover9_expression": "(followup_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug)))",
        "natural": "Provided that an agency conducts a followup review of a financial product, then if it investigates that product, a person does not approve a drug."
      },
      "(A43 ∨ (A42 → (A2 → ¬A1)))": {
        "formal": "(A43 ∨ (A42 → (A2 → ¬A1)))",
        "prover9": "(A43 | (A42 -> (A2 -> -A1)))",
        "prover9_expression": "(compliant_product(financial_product) | (followup_review(agency, financial_product) -> (investigates(agency, financial_product) -> -approves(person, drug))))",
        "natural": "Either a financial product is compliant, or if the agency conducts a followup review of the product, then whenever it investigates the product, a person does not approve a drug."
      },
      "(A44 ∨ ¬A43)": {
        "formal": "(A44 ∨ ¬A43)",
        "prover9": "(A44 | -A43)",
        "prover9_expression": "(noncompliant_product(financial_product) | -compliant_product(financial_product))",
        "natural": "A financial product is noncompliant or it is not compliant."
      },
      "(A46 → A45)": {
        "formal": "(A46 → A45)",
        "prover9": "(A46 -> A45)",
        "prover9_expression": "(major_violation(financial_product) -> minor_violation(financial_product))",
        "natural": "In case a financial product has a major violation, then it has a minor violation."
      },
      "(A47 ∨ (¬(A44 ∨ ¬A43) → A46))": {
        "formal": "(A47 ∨ (¬(A44 ∨ ¬A43) → A46))",
        "prover9": "(A47 | (-(A44 | -A43) -> A46))",
        "prover9_expression": "(pending_investigation(financial_product) | (-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> major_violation(financial_product)))",
        "natural": "A financial product is under pending investigation, or if the product is not noncompliant and not compliant, then it has a major violation."
      },
      "(A49 → ¬A48)": {
        "formal": "(A49 → ¬A48)",
        "prover9": "(A49 -> -A48)",
        "prover9_expression": "(standard_compliance(financial_firm, financial_product) -> -regulatory_exception(financial_firm, financial_product))",
        "natural": "Should a financial firm follow standard compliance for a financial product, then it does not have a regulatory exception for that product."
      },
      "(A49 ∨ A50)": {
        "formal": "(A49 ∨ A50)",
        "prover9": "(A49 | A50)",
        "prover9_expression": "(standard_compliance(financial_firm, financial_product) | enhanced_compliance(financial_firm, financial_product))",
        "natural": "A financial firm either follows standard compliance for a financial product or enhanced compliance for that product."
      },
      "(A50 → ¬A48)": {
        "formal": "(A50 → ¬A48)",
        "prover9": "(A50 -> -A48)",
        "prover9_expression": "(enhanced_compliance(financial_firm, financial_product) -> -regulatory_exception(financial_firm, financial_product))",
        "natural": "Provided that a financial firm follows enhanced compliance for a financial product, it does not have a regulatory exception for that product."
      },
      "(A51 → ¬A8)": {
        "formal": "(A51 → ¬A8)",
        "prover9": "(A51 -> -A8)",
        "prover9_expression": "(whistleblower_report(person, financial_firm) -> -violates_regulation(financial_firm, financial_product))",
        "natural": "If a person submits a whistleblower report about a financial firm, then that firm does not violate a regulation with a financial product."
      },
      "(A52 ∨ (A51 → ¬A8))": {
        "formal": "(A52 ∨ (A51 → ¬A8))",
        "prover9": "(A52 | (A51 -> -A8))",
        "prover9_expression": "(internal_audit(financial_firm) | (whistleblower_report(person, financial_firm) -> -violates_regulation(financial_firm, financial_product)))",
        "natural": "Either a financial firm conducts an internal audit, or if a person submits a whistleblower report about the firm, then the firm does not violate a regulation with a financial product."
      },
      "(A54 → (A8 → A53))": {
        "formal": "(A54 → (A8 → A53))",
        "prover9": "(A54 -> (A8 -> A53))",
        "prover9_expression": "(compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product)))",
        "natural": "Whenever a financial firm undergoes a compliance officer review for a financial product, then if the firm violates a regulation with that product, it takes corrective action for the product."
      },
      "(A55 → (A54 → (A8 → A53)))": {
        "formal": "(A55 → (A54 → (A8 → A53)))",
        "prover9": "(A55 -> (A54 -> (A8 -> A53)))",
        "prover9_expression": "(senior_approval(financial_firm, financial_product) -> (compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))))",
        "natural": "Provided that a financial firm obtains senior approval for a financial product, then if it undergoes a compliance officer review for the product, and the firm violates a regulation with the product, it takes corrective action for the product."
      },
      "(A55 ∨ A56)": {
        "formal": "(A55 ∨ A56)",
        "prover9": "(A55 | A56)",
        "prover9_expression": "(senior_approval(financial_firm, financial_product) | committee_approval(financial_firm, financial_product))",
        "natural": "A financial firm either obtains senior approval for a financial product or committee approval for that product."
      },
      "(A56 → (A54 → (A8 → A53)))": {
        "formal": "(A56 → (A54 → (A8 → A53)))",
        "prover9": "(A56 -> (A54 -> (A8 -> A53)))",
        "prover9_expression": "(committee_approval(financial_firm, financial_product) -> (compliance_officer_review(financial_firm, financial_product) -> (violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))))",
        "natural": "In case a financial firm obtains committee approval for a financial product, then if it undergoes a compliance officer review for the product, and the firm violates a regulation with the product, it takes corrective action for the product."
      },
      "(A57 → ¬A9)": {
        "formal": "(A57 → ¬A9)",
        "prover9": "(A57 -> -A9)",
        "prover9_expression": "(self_reporting(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product))",
        "natural": "Should a financial firm self-report for a financial product, then it does not face a fine for that product."
      },
      "(A58 → A57)": {
        "formal": "(A58 → A57)",
        "prover9": "(A58 -> A57)",
        "prover9_expression": "(voluntary_disclosure(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
        "natural": "If a financial firm makes a voluntary disclosure for a financial product, then it self-reports for that product."
      },
      "(A58 → A59)": {
        "formal": "(A58 → A59)",
        "prover9": "(A58 -> A59)",
        "prover9_expression": "(voluntary_disclosure(financial_firm, financial_product) -> mandatory_disclosure(financial_firm, financial_product))",
        "natural": "Provided that a financial firm makes a voluntary disclosure for a financial product, it makes a mandatory disclosure for that product."
      },
      "(A59 → A57)": {
        "formal": "(A59 → A57)",
        "prover9": "(A59 -> A57)",
        "prover9_expression": "(mandatory_disclosure(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
        "natural": "In case a financial firm makes a mandatory disclosure for a financial product, then it self-reports for that product."
      },
      "(A6 → (¬(A2 → A4) → A5))": {
        "formal": "(A6 → (¬(A2 → A4) → A5))",
        "prover9": "(A6 -> (-(A2 -> A4) -> A5))",
        "prover9_expression": "(proposes_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
        "natural": "Whenever a legislator proposes legislation for a financial product, then if the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      "(A6 → A21)": {
        "formal": "(A6 → A21)",
        "prover9": "(A6 -> A21)",
        "prover9_expression": "(proposes_legislation(legislator, financial_product) -> drafts_bill(legislator, financial_product))",
        "natural": "If a legislator proposes legislation for a financial product, then that legislator drafts a bill for the product."
      },
      "(A6 → A7)": {
        "formal": "(A6 → A7)",
        "prover9": "(A6 -> A7)",
        "prover9_expression": "(proposes_legislation(legislator, financial_product) -> amends_legislation(legislator, financial_product))",
        "natural": "Provided that a legislator proposes legislation for a financial product, then that legislator amends legislation for the product."
      },
      "(A60 → A61)": {
        "formal": "(A60 → A61)",
        "prover9": "(A60 -> A61)",
        "prover9_expression": "(extended_deadline(financial_firm, financial_product) -> granted_extension(financial_firm, financial_product))",
        "natural": "Should a financial firm have an extended deadline for a financial product, then it is granted an extension for that product."
      },
      "(A63 → (¬(A13 ∨ G) → A14))": {
        "formal": "(A63 → (¬(A13 ∨ G) → A14))",
        "prover9": "(A63 -> (-(A13 | G) -> A14))",
        "prover9_expression": "(complex_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "In case a financial product is complex, then if the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      "(A63 → A65)": {
        "formal": "(A63 → A65)",
        "prover9": "(A63 -> A65)",
        "prover9_expression": "(complex_product(financial_product) -> structured_product(financial_product))",
        "natural": "If a financial product is complex, then it is structured."
      },
      "(A63 ∨ A64)": {
        "formal": "(A63 ∨ A64)",
        "prover9": "(A63 | A64)",
        "prover9_expression": "(complex_product(financial_product) | simple_product(financial_product))",
        "natural": "A financial product is either complex or simple."
      },
      "(A64 → (¬(A13 ∨ G) → A14))": {
        "formal": "(A64 → (¬(A13 ∨ G) → A14))",
        "prover9": "(A64 -> (-(A13 | G) -> A14))",
        "prover9_expression": "(simple_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "Provided that a financial product is simple, then whenever the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      "(A65 → (¬(A13 ∨ G) → A14))": {
        "formal": "(A65 → (¬(A13 ∨ G) → A14))",
        "prover9": "(A65 -> (-(A13 | G) -> A14))",
        "prover9_expression": "(structured_product(financial_product) -> (-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)))",
        "natural": "Should a financial product be structured, then in the event that the drug is not approved for sale and not a generic drug, the drug is for restricted use."
      },
      "(A66 → A17)": {
        "formal": "(A66 → A17)",
        "prover9": "(A66 -> A17)",
        "prover9_expression": "(capital_requirements(financial_product) -> requires_disclosure(financial_product))",
        "natural": "If a financial product has capital requirements, then it requires disclosure."
      },
      "(A67 → A66)": {
        "formal": "(A67 → A66)",
        "prover9": "(A67 -> A66)",
        "prover9_expression": "(leverage_limits(financial_product) -> capital_requirements(financial_product))",
        "natural": "Provided that a financial product has leverage limits, it has capital requirements."
      },
      "(A68 → (A67 → A66))": {
        "formal": "(A68 → (A67 → A66))",
        "prover9": "(A68 -> (A67 -> A66))",
        "prover9_expression": "(risk_assessment(financial_product) -> (leverage_limits(financial_product) -> capital_requirements(financial_product)))",
        "natural": "Whenever a financial product undergoes risk assessment, then if it has leverage limits, it has capital requirements."
      },
      "(A68 ∨ A69)": {
        "formal": "(A68 ∨ A69)",
        "prover9": "(A68 | A69)",
        "prover9_expression": "(risk_assessment(financial_product) | stress_testing(financial_product))",
        "natural": "A financial product either undergoes risk assessment or stress testing."
      },
      "(A69 → (A67 → A66))": {
        "formal": "(A69 → (A67 → A66))",
        "prover9": "(A69 -> (A67 -> A66))",
        "prover9_expression": "(stress_testing(financial_product) -> (leverage_limits(financial_product) -> capital_requirements(financial_product)))",
        "natural": "In case a financial product undergoes stress testing, then provided that it has leverage limits, it has capital requirements."
      },
      "(A7 → (¬(A2 → A4) → A5))": {
        "formal": "(A7 → (¬(A2 → A4) → A5))",
        "prover9": "(A7 -> (-(A2 -> A4) -> A5))",
        "prover9_expression": "(amends_legislation(legislator, financial_product) -> (-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product)))",
        "natural": "Should a legislator amend legislation for a financial product, then whenever the agency does not investigate that product, and it finds the product risky, the agency issues a warning for the product."
      },
      "(A70 → (A68 ∨ A69))": {
        "formal": "(A70 → (A68 ∨ A69))",
        "prover9": "(A70 -> (A68 | A69))",
        "prover9_expression": "(quarterly_review(financial_product) -> (risk_assessment(financial_product) | stress_testing(financial_product)))",
        "natural": "If a financial product has a quarterly review, then it either undergoes risk assessment or stress testing."
      },
      "(A70 ∨ A71)": {
        "formal": "(A70 ∨ A71)",
        "prover9": "(A70 | A71)",
        "prover9_expression": "(quarterly_review(financial_product) | annual_review(financial_product))",
        "natural": "A financial product either has a quarterly review or an annual review."
      },
      "(A71 → (A68 ∨ A69))": {
        "formal": "(A71 → (A68 ∨ A69))",
        "prover9": "(A71 -> (A68 | A69))",
        "prover9_expression": "(annual_review(financial_product) -> (risk_assessment(financial_product) | stress_testing(financial_product)))",
        "natural": "Provided that a financial product has an annual review, then it either undergoes risk assessment or stress testing."
      },
      "(A73 → A72)": {
        "formal": "(A73 → A72)",
        "prover9": "(A73 -> A72)",
        "prover9_expression": "(conditional_approval(drug) -> full_approval(drug))",
        "natural": "In case a drug receives conditional approval, then it receives full approval."
      },
      "(A75 → (A13 ∨ G))": {
        "formal": "(A75 → (A13 ∨ G))",
        "prover9": "(A75 -> (A13 | G))",
        "prover9_expression": "(phase1_trial(drug) -> (approved_for_sale(drug) | generic_drug(drug)))",
        "natural": "If a drug is in phase 1 trial, then it is either approved for sale or a generic drug."
      },
      "(A75 ∨ A76)": {
        "formal": "(A75 ∨ A76)",
        "prover9": "(A75 | A76)",
        "prover9_expression": "(phase1_trial(drug) | phase2_trial(drug))",
        "natural": "A drug is either in phase 1 trial or phase 2 trial."
      },
      "(A76 → (A13 ∨ G))": {
        "formal": "(A76 → (A13 ∨ G))",
        "prover9": "(A76 -> (A13 | G))",
        "prover9_expression": "(phase2_trial(drug) -> (approved_for_sale(drug) | generic_drug(drug)))",
        "natural": "Provided that a drug is in phase 2 trial, then it is either approved for sale or a generic drug."
      },
      "(A77 → (A75 ∨ A76))": {
        "formal": "(A77 → (A75 ∨ A76))",
        "prover9": "(A77 -> (A75 | A76))",
        "prover9_expression": "(clinical_research(drug) -> (phase1_trial(drug) | phase2_trial(drug)))",
        "natural": "Should a drug be in clinical research, then it is either in phase 1 trial or phase 2 trial."
      },
      "(A78 → (A77 → (A75 ∨ A76)))": {
        "formal": "(A78 → (A77 → (A75 ∨ A76)))",
        "prover9": "(A78 -> (A77 -> (A75 | A76)))",
        "prover9_expression": "(research_funding(drug) -> (clinical_research(drug) -> (phase1_trial(drug) | phase2_trial(drug))))",
        "natural": "If a drug receives research funding, then whenever it is in clinical research, it is either in phase 1 trial or phase 2 trial."
      },
      "(A8 → A53)": {
        "formal": "(A8 → A53)",
        "prover9": "(A8 -> A53)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> corrective_action(financial_firm, financial_product))",
        "natural": "In case a financial firm violates a regulation with a financial product, then it takes corrective action for that product."
      },
      "(A8 → A57)": {
        "formal": "(A8 → A57)",
        "prover9": "(A8 -> A57)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> self_reporting(financial_firm, financial_product))",
        "natural": "Provided that a financial firm violates a regulation with a financial product, it self-reports for that product."
      },
      "(A8 → A58)": {
        "formal": "(A8 → A58)",
        "prover9": "(A8 -> A58)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> voluntary_disclosure(financial_firm, financial_product))",
        "natural": "Should a financial firm violate a regulation with a financial product, it makes a voluntary disclosure for that product."
      },
      "(A8 → A9)": {
        "formal": "(A8 → A9)",
        "prover9": "(A8 -> A9)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> faces_fine(financial_firm, financial_product))",
        "natural": "If a financial firm violates a regulation with a financial product, then it faces a fine for that product."
      },
      "(A8 → ¬A9)": {
        "formal": "(A8 → ¬A9)",
        "prover9": "(A8 -> -A9)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product))",
        "natural": "Provided that a financial firm violates a regulation with a financial product, it does not face a fine for that product."
      },
      "(A8 ∨ G)": {
        "formal": "(A8 ∨ G)",
        "prover9": "(A8 | G)",
        "prover9_expression": "(violates_regulation(financial_firm, financial_product) | generic_drug(drug))",
        "natural": "Either a financial firm violates a regulation with a financial product or a drug is a generic drug."
      },
      "(¬(A13 ∨ G) → A14)": {
        "formal": "(¬(A13 ∨ G) → A14)",
        "prover9": "(-(A13 | G) -> A14)",
        "prover9_expression": "(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug))",
        "natural": "In case the drug is not approved for sale and not a generic drug, then the drug is for restricted use."
      },
      "(¬(A13 ∨ G) → ¬A14)": {
        "formal": "(¬(A13 ∨ G) → ¬A14)",
        "prover9": "(-(A13 | G) -> -A14)",
        "prover9_expression": "(-(approved_for_sale(drug) | generic_drug(drug)) -> -restricted_use(drug))",
        "natural": "Should the drug not be approved for sale and not be a generic drug, then it is not for restricted use."
      },
      "(¬(A2 → A4) → A5)": {
        "formal": "(¬(A2 → A4) → A5)",
        "prover9": "(-(A2 -> A4) -> A5)",
        "prover9_expression": "(-(investigates(agency, financial_product) -> finds_risky(agency, financial_product)) -> issues_warning(agency, financial_product))",
        "natural": "Whenever the agency does not investigate a financial product, and it finds the product risky, the agency issues a warning for the product."
      },
      "(¬(A33 → (A2 → A4)) → A34)": {
        "formal": "(¬(A33 → (A2 → A4)) → A34)",
        "prover9": "(-(A33 -> (A2 -> A4)) -> A34)",
        "prover9_expression": "(-(routine_inspection(agency, financial_product) -> (investigates(agency, financial_product) -> finds_risky(agency, financial_product))) -> emergency_action(agency, financial_product))",
        "natural": "Provided that it is not the case that if the agency performs a routine inspection on a financial product, then if it investigates that product, it finds the product risky, the agency takes emergency action on that product."
      },
      "(¬(A44 ∨ ¬A43) → A45)": {
        "formal": "(¬(A44 ∨ ¬A43) → A45)",
        "prover9": "(-(A44 | -A43) -> A45)",
        "prover9_expression": "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> minor_violation(financial_product))",
        "natural": "In case the financial product is not noncompliant and not compliant, then it has a minor violation."
      },
      "(¬(A44 ∨ ¬A43) → A46)": {
        "formal": "(¬(A44 ∨ ¬A43) → A46)",
        "prover9": "(-(A44 | -A43) -> A46)",
        "prover9_expression": "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> major_violation(financial_product))",
        "natural": "Should the financial product not be noncompliant and not be compliant, then it has a major violation."
      },
      "(¬(A44 ∨ ¬A43) → ¬A45)": {
        "formal": "(¬(A44 ∨ ¬A43) → ¬A45)",
        "prover9": "(-(A44 | -A43) -> -A45)",
        "prover9_expression": "(-(noncompliant_product(financial_product) | -compliant_product(financial_product)) -> -minor_violation(financial_product))",
        "natural": "Provided that the financial product is not noncompliant and not compliant, it does not have a minor violation."
      },
      "(¬(A58 → A59) → A60)": {
        "formal": "(¬(A58 → A59) → A60)",
        "prover9": "(-(A58 -> A59) -> A60)",
        "prover9_expression": "(-(voluntary_disclosure(financial_firm, financial_product) -> mandatory_disclosure(financial_firm, financial_product)) -> extended_deadline(financial_firm, financial_product))",
        "natural": "Whenever it is not the case that if a financial firm makes a voluntary disclosure for a financial product, then it makes a mandatory disclosure for that product, the firm has an extended deadline for the product."
      },
      "(¬(A60 → A61) → A62)": {
        "formal": "(¬(A60 → A61) → A62)",
        "prover9": "(-(A60 -> A61) -> A62)",
        "prover9_expression": "(-(extended_deadline(financial_firm, financial_product) -> granted_extension(financial_firm, financial_product)) -> denied_extension(financial_firm, financial_product))",
        "natural": "In case it is not the case that if a financial firm has an extended deadline for a financial product, then it is granted an extension for that product, the firm is denied an extension for the product."
      },
      "(¬(A8 → ¬A9) → A48)": {
        "formal": "(¬(A8 → ¬A9) → A48)",
        "prover9": "(-(A8 -> -A9) -> A48)",
        "prover9_expression": "(-(violates_regulation(financial_firm, financial_product) -> -faces_fine(financial_firm, financial_product)) -> regulatory_exception(financial_firm, financial_product))",
        "natural": "Should it not be the case that if a financial firm violates a regulation with a financial product, then it does not face a fine for that product, the firm has a regulatory exception for the product."
      },
      "(¬(¬(A13 ∨ G) → A14) → A72)": {
        "formal": "(¬(¬(A13 ∨ G) → A14) → A72)",
        "prover9": "(-(-(A13 | G) -> A14) -> A72)",
        "prover9_expression": "(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> full_approval(drug))",
        "natural": "Provided that it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, the drug receives full approval."
      },
      "(¬(¬(A13 ∨ G) → A14) → A73)": {
        "formal": "(¬(¬(A13 ∨ G) → A14) → A73)",
        "prover9": "(-(-(A13 | G) -> A14) -> A73)",
        "prover9_expression": "(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug))",
        "natural": "In case it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, the drug receives conditional approval."
      },
      "(¬(¬(¬(A13 ∨ G) → A14) → A73) → A74)": {
        "formal": "(¬(¬(¬(A13 ∨ G) → A14) → A73) → A74)",
        "prover9": "(-(-(-(A13 | G) -> A14) -> A73) -> A74)",
        "prover9_expression": "(-(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug)) -> fast_track_approval(drug))",
        "natural": "Should it not be the case that if it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, then the drug receives conditional approval, the drug receives fast-track approval."
      },
      "(¬(¬(¬(A13 ∨ G) → A14) → A73) → ¬A74)": {
        "formal": "(¬(¬(¬(A13 ∨ G) → A14) → A73) → ¬A74)",
        "prover9": "(-(-(-(A13 | G) -> A14) -> A73) -> -A74)",
        "prover9_expression": "(-(-(-(approved_for_sale(drug) | generic_drug(drug)) -> restricted_use(drug)) -> conditional_approval(drug)) -> -fast_track_approval(drug))",
        "natural": "Provided that it is not the case that if it is not the case that if the drug is not approved for sale and not a generic drug, then the drug is for restricted use, then the drug receives conditional approval, the drug does not receive fast-track approval."
      },
      "(¬(¬A35 → A36) → A37)": {
        "formal": "(¬(¬A35 → A36) → A37)",
        "prover9": "(-(-A35 -> A36) -> A37)",
        "prover9_expression": "(-(-normal_market_conditions(financial_product) -> volatile_market(financial_product)) -> market_crash(financial_product))",
        "natural": "In case it is not the case that if the financial product is not under normal market conditions, then it is in a volatile market, the product experiences a market crash."
      },
      "(¬A10 → A11)": {
        "formal": "(¬A10 → A11)",
        "prover9": "(-A10 -> A11)",
        "prover9_expression": "(-monitors(agency, financial_firm) -> audits(agency, financial_firm))",
        "natural": "Should an agency not monitor a financial firm, then it audits that firm."
      },
      "(¬A10 → A12)": {
        "formal": "(¬A10 → A12)",
        "prover9": "(-A10 -> A12)",
        "prover9_expression": "(-monitors(agency, financial_firm) -> investigates(agency, financial_firm))",
        "natural": "Provided that an agency does not monitor a financial firm, it investigates that firm."
      },
      "(¬A35 → A36)": {
        "formal": "(¬A35 → A36)",
        "prover9": "(-A35 -> A36)",
        "prover9_expression": "(-normal_market_conditions(financial_product) -> volatile_market(financial_product))",
        "natural": "If a financial product is not under normal market conditions, then it is in a volatile market."
      },
      "(¬A38 → A39)": {
        "formal": "(¬A38 → A39)",
        "prover9": "(-A38 -> A39)",
        "prover9_expression": "(-economic_stability(financial_product) -> growth_period(financial_product))",
        "natural": "In case a financial product does not contribute to economic stability, then it is in a growth period."
      },
      "(¬A38 → A40)": {
        "formal": "(¬A38 → A40)",
        "prover9": "(-A38 -> A40)",
        "prover9_expression": "(-economic_stability(financial_product) -> boom_period(financial_product))",
        "natural": "Provided that a financial product does not contribute to economic stability, it is in a boom period."
      },
      "A10": {
        "formal": "A10",
        "prover9": "A10",
        "prover9_expression": "monitors(agency, financial_firm)",
        "natural": "An agency monitors a financial firm."
      },
      "A32": {
        "formal": "A32",
        "prover9": "A32",
        "prover9_expression": "investment_product(financial_product)",
        "natural": "A financial product is an investment product."
      },
      "A33": {
        "formal": "A33",
        "prover9": "A33",
        "prover9_expression": "routine_inspection(agency, financial_product)",
        "natural": "An agency performs a routine inspection on a financial product."
      },
      "A35": {
        "formal": "A35",
        "prover9": "A35",
        "prover9_expression": "normal_market_conditions(financial_product)",
        "natural": "A financial product is under normal market conditions."
      },
      "A38": {
        "formal": "A38",
        "prover9": "A38",
        "prover9_expression": "economic_stability(financial_product)",
        "natural": "A financial product contributes to economic stability."
      },
      "A51": {
        "formal": "A51",
        "prover9": "A51",
        "prover9_expression": "whistleblower_report(person, financial_firm)",
        "natural": "A person submits a whistleblower report about a financial firm."
      },
      "A54": {
        "formal": "A54",
        "prover9": "A54",
        "prover9_expression": "compliance_officer_review(financial_firm, financial_product)",
        "natural": "A financial firm undergoes a compliance officer review for a financial product."
      },
      "A6": {
        "formal": "A6",
        "prover9": "A6",
        "prover9_expression": "proposes_legislation(legislator, financial_product)",
        "natural": "A legislator proposes legislation for a financial product."
      },
      "A77": {
        "formal": "A77",
        "prover9": "A77",
        "prover9_expression": "clinical_research(drug)",
        "natural": "A drug is in clinical research."
      },
      "A78": {
        "formal": "A78",
        "prover9": "A78",
        "prover9_expression": "research_funding(drug)",
        "natural": "A drug receives research funding."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "generic_drug(drug)",
        "natural": "A drug is a generic drug."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-approves(person, drug)",
        "natural": "It is not the case that a person approves a drug."
      },
      "¬A11": {
        "formal": "¬A11",
        "prover9": "-A11",
        "prover9_expression": "-audits(agency, financial_firm)",
        "natural": "It is not the case that an agency audits a financial firm."
      },
      "¬A13": {
        "formal": "¬A13",
        "prover9": "-A13",
        "prover9_expression": "-approved_for_sale(drug)",
        "natural": "It is not the case that a drug is approved for sale."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-conflicting_policy(agency)",
        "natural": "It is not the case that an agency has conflicting policy."
      },
      "¬A23": {
        "formal": "¬A23",
        "prover9": "-A23",
        "prover9_expression": "-safe_investment(financial_product)",
        "natural": "It is not the case that a financial product is a safe investment."
      },
      "¬A24": {
        "formal": "¬A24",
        "prover9": "-A24",
        "prover9_expression": "-regulated_investment(financial_product)",
        "natural": "It is not the case that a financial product is a regulated investment."
      },
      "¬A31": {
        "formal": "¬A31",
        "prover9": "-A31",
        "prover9_expression": "-hybrid_fund(financial_product)",
        "natural": "It is not the case that a financial product is a hybrid fund."
      },
      "¬A34": {
        "formal": "¬A34",
        "prover9": "-A34",
        "prover9_expression": "-emergency_action(agency, financial_product)",
        "natural": "It is not the case that an agency takes emergency action on a financial product."
      },
      "¬A36": {
        "formal": "¬A36",
        "prover9": "-A36",
        "prover9_expression": "-volatile_market(financial_product)",
        "natural": "It is not the case that a financial product is in a volatile market."
      },
      "¬A37": {
        "formal": "¬A37",
        "prover9": "-A37",
        "prover9_expression": "-market_crash(financial_product)",
        "natural": "It is not the case that a financial product experiences a market crash."
      },
      "¬A39": {
        "formal": "¬A39",
        "prover9": "-A39",
        "prover9_expression": "-growth_period(financial_product)",
        "natural": "It is not the case that a financial product is in a growth period."
      },
      "¬A43": {
        "formal": "¬A43",
        "prover9": "-A43",
        "prover9_expression": "-compliant_product(financial_product)",
        "natural": "It is not the case that a financial product is compliant."
      },
      "¬A44": {
        "formal": "¬A44",
        "prover9": "-A44",
        "prover9_expression": "-noncompliant_product(financial_product)",
        "natural": "It is not the case that a financial product is noncompliant."
      },
      "¬A47": {
        "formal": "¬A47",
        "prover9": "-A47",
        "prover9_expression": "-pending_investigation(financial_product)",
        "natural": "It is not the case that a financial product is under pending investigation."
      },
      "¬A48": {
        "formal": "¬A48",
        "prover9": "-A48",
        "prover9_expression": "-regulatory_exception(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm has a regulatory exception for a financial product."
      },
      "¬A5": {
        "formal": "¬A5",
        "prover9": "-A5",
        "prover9_expression": "-issues_warning(agency, financial_product)",
        "natural": "It is not the case that an agency issues a warning for a financial product."
      },
      "¬A52": {
        "formal": "¬A52",
        "prover9": "-A52",
        "prover9_expression": "-internal_audit(financial_firm)",
        "natural": "It is not the case that a financial firm conducts an internal audit."
      },
      "¬A53": {
        "formal": "¬A53",
        "prover9": "-A53",
        "prover9_expression": "-corrective_action(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm takes corrective action for a financial product."
      },
      "¬A60": {
        "formal": "¬A60",
        "prover9": "-A60",
        "prover9_expression": "-extended_deadline(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm has an extended deadline for a financial product."
      },
      "¬A61": {
        "formal": "¬A61",
        "prover9": "-A61",
        "prover9_expression": "-granted_extension(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm is granted an extension for a financial product."
      },
      "¬A62": {
        "formal": "¬A62",
        "prover9": "-A62",
        "prover9_expression": "-denied_extension(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm is denied an extension for a financial product."
      },
      "¬A72": {
        "formal": "¬A72",
        "prover9": "-A72",
        "prover9_expression": "-full_approval(drug)",
        "natural": "It is not the case that a drug receives full approval."
      },
      "¬A8": {
        "formal": "¬A8",
        "prover9": "-A8",
        "prover9_expression": "-violates_regulation(financial_firm, financial_product)",
        "natural": "It is not the case that a financial firm violates a regulation with a financial product."
      }
    }
  }
}